<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21887284</article-id><article-id pub-id-type="pmc">3160956</article-id><article-id pub-id-type="publisher-id">PONE-D-11-03441</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0023609</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Cardiovascular</subject><subj-group><subject>Cardiovascular Pharmacology</subject><subject>Hypertension</subject><subject>Myocardial Infarction</subject></subj-group></subj-group><subj-group><subject>Clinical Genetics</subject><subj-group><subject>Personalized Medicine</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Cardiovascular Disease Epidemiology</subject><subject>Genetic Epidemiology</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension</article-title><alt-title alt-title-type="running-head">CVD Pharmacogenetics of MMP9 and MMP12</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tanner</surname><given-names>Rikki M.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lynch</surname><given-names>Amy I.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brophy</surname><given-names>Victoria H.</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Eckfeldt</surname><given-names>John H.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Barry R.</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ford</surname><given-names>Charles E.</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Boerwinkle</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arnett</surname><given-names>Donna K.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, United States of America</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Human Genetics, Roche Molecular Systems, Pleasanton, California, United States of America</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>School of Public Health, University of Texas at Houston, Houston, Texas, United States of America</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Human Genetics Center, University of Texas at Houston, Houston, Texas, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Kronenberg</surname><given-names>Florian</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Innsbruck Medical University, Austria</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>arnett@uab.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JE BD CF EB DA. Performed the experiments: EB. Analyzed the data: RT AL. Contributed reagents/materials/analysis tools: VB. Wrote the paper: RT DA AL.</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>24</day><month>8</month><year>2011</year></pub-date><volume>6</volume><issue>8</issue><elocation-id>e23609</elocation-id><history><date date-type="received"><day>16</day><month>2</month><year>2011</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2011</year></date></history><permissions><copyright-statement>Tanner et al.</copyright-statement><copyright-year>2011</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Objectives</title><p>MMP-9 and -12 function in tissue remodeling and may play roles in cardiovascular disease (CVD). We assessed associations of four MMP polymorphisms and three antihypertensive drugs with cardiovascular outcomes.</p></sec><sec><title>Methods</title><p>Hypertensives (n&#x0200a;=&#x0200a;42,418) from a double-blind, randomized, clinical trial were randomized to chlorthalidone, amlodipine, lisinopril, or doxazosin treatment (mean follow up, 4.9 years). The primary outcome was coronary heart disease (CHD). Secondary outcomes included combined CHD, all CVD outcomes combined, stroke, heart failure (HF), and mortality. Genotype-treatment interactions were tested.</p></sec><sec><title>Results</title><p>There were 38,698 participants genotyped for at least one of the polymorphisms included here. For <italic>MMP9</italic> R668Q (rs2274756), lower hazard ratios (HRs) were found for AA subjects for most outcomes when treated with chlorthalidone versus amlodipine (eg., CCHD: GG&#x0200a;=&#x0200a;1.00, GA&#x0200a;=&#x0200a;1.01, AA&#x0200a;=&#x0200a;0.64; <italic>P</italic>&#x0200a;=&#x0200a;0.038). For <italic>MMP9</italic> R279Q (rs17576), modest pharmacogenetic findings were observed for combined CHD and the composite CVD outcome. For <italic>MMP12</italic> N122S (rs652438), lower HRs were observed for CHD in subjects carrying at least one G allele and being treated with chlorthalidone versus lisinopril (CHD: AA&#x0200a;=&#x0200a;1.07, AG&#x0200a;=&#x0200a;0.80, GG&#x0200a;=&#x0200a;0.49; <italic>P</italic>&#x0200a;=&#x0200a;0.005). In the lisinopril-amlodipine comparison, higher HRs were observed for participants having at least one G allele at the <italic>MMP12</italic> N122S locus (CHD: AA&#x0200a;=&#x0200a;0.94, AG&#x0200a;=&#x0200a;1.19, GG&#x0200a;=&#x0200a;1.93; <italic>P</italic>&#x0200a;=&#x0200a;0.041). For <italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109), no pharmacogenetic effect was found for the primary outcome, although lower HRs were observed for AA homozygotes in the chlorthalidone-amlodipine comparison for HF (<italic>P</italic>&#x0200a;=&#x0200a;0.015).</p></sec><sec><title>Conclusions</title><p>We observed interactions between antihypertensive drugs and <italic>MMP9</italic> and <italic>MMP12</italic> for CHD and composite CVD. The data suggest that these genes may provide useful clinical information with respect to treatment decisions.</p></sec></abstract><counts><page-count count="12"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases which play a role in connective tissue remodeling. Circulating levels of MMPs are associated with many cardiovascular diseases (CVDs), including atherosclerosis, myocardial infarction (MI), and heart failure <xref rid="pone.0023609-Galis1" ref-type="bibr">[1]</xref>, <xref rid="pone.0023609-Hlatky1" ref-type="bibr">[2]</xref>, <xref rid="pone.0023609-Hutchinson1" ref-type="bibr">[3]</xref>. MMP-9 (gelatinase-B) functions in the degradation of type IV and V collagens, and its levels are raised in individuals with hypertension, acute coronary syndrome, and acute MI <xref rid="pone.0023609-Hlatky1" ref-type="bibr">[2]</xref>, <xref rid="pone.0023609-Zhou1" ref-type="bibr">[4]</xref>, <xref rid="pone.0023609-Kai1" ref-type="bibr">[5]</xref>. MMP-12, (macrophage metalloelastase) is up-regulated in atherosclerotic lesions and aneurysms and may contribute to the activation of other MMPs, which, in turn, degrade other extracellular matrix proteins <xref rid="pone.0023609-Liang1" ref-type="bibr">[6]</xref>. A recent study found that MMP-12 production by macrophages plays a role in the transition from fatty acids to fibrous plaques during the progression of atherosclerosis <xref rid="pone.0023609-Yamada1" ref-type="bibr">[7]</xref>. Given MMPs' associations and possible causal connections with CVD, these enzymes represent potential drug targets for CVD treatment and prevention. In fact, amlodipine and lercanidipine have been shown to influence MMP-9 plasma levels and activity <xref rid="pone.0023609-Zervoudaki1" ref-type="bibr">[8]</xref>, <xref rid="pone.0023609-Zervoudaki2" ref-type="bibr">[9]</xref>, <xref rid="pone.0023609-Martinez1" ref-type="bibr">[10]</xref>. ACE inhibitors may also affect MMP levels <xref rid="pone.0023609-Jin1" ref-type="bibr">[11]</xref>, <xref rid="pone.0023609-Reinhardt1" ref-type="bibr">[12]</xref>, <xref rid="pone.0023609-Yamamoto1" ref-type="bibr">[13]</xref>, <xref rid="pone.0023609-Liebetrau1" ref-type="bibr">[14]</xref>. Attempts have been made to assess associations of MMP gene variants with disease and risk phenotypes <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>, <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>, <xref rid="pone.0023609-Su1" ref-type="bibr">[17]</xref>, <xref rid="pone.0023609-Joos1" ref-type="bibr">[18]</xref>, <xref rid="pone.0023609-Han1" ref-type="bibr">[19]</xref>. For example, individuals carrying the <italic>MMP9</italic> 279Q allele had higher plasma levels of MMP-9 and higher risk of cardiovascular events than patients homozygous for the 279R allele (<italic>P</italic>&#x0200a;=&#x0200a;0.02) <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>. The <italic>MMP9</italic> R279Q polymorphism is a glutamine to arginine substitution located in the catalytic domain of MMP-9 <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>, <xref rid="pone.0023609-Hirose1" ref-type="bibr">[20]</xref> and plausibly represents a loss-of-function mutation <xref rid="pone.0023609-Natividad1" ref-type="bibr">[21]</xref>. The R668Q variant of <italic>MMP9</italic> lies within exon 12. This missense mutation lies in the hemopexin-like domain and probably functions in substrate binding <xref rid="pone.0023609-Han1" ref-type="bibr">[19]</xref>. The <italic>MMP12</italic> &#x02212;82A&#x0003e;G variant, which lies in the gene's promoter region, affects transcription factor binding affinity, with the A allele associated with increased promoter activity <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>, <xref rid="pone.0023609-Joos1" ref-type="bibr">[18]</xref>; this variant has been shown to affect coronary artery luminal diameter <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>. The <italic>MMP12</italic> N122S variant lies within the gene's coding region; although this variant has been associated with endpoints such as breast cancer prognosis <xref rid="pone.0023609-Shin1" ref-type="bibr">[22]</xref> and diabetic nephropathy <xref rid="pone.0023609-Kure1" ref-type="bibr">[23]</xref>, the functional significance of the single-nucleotide polymorphism (SNP) is unknown. Given these and other MMP genetic associations with cardiovascular phenotypes and known molecular interactions between antihypertensive drugs and some MMPs, MMP genes may modify rates of CVD outcomes differently for different antihypertensive treatments. We tested whether hypertensive participants in the Genetics of Hypertension Associated Treatment (GenHAT) Study genotyped for <italic>MMP9</italic> variants R279Q and R668Q and for <italic>MMP12</italic> variants N122S and &#x02212;82A&#x0003e;G and randomized to either the diuretic chlorthalidone, the calcium channel blocker amlodipine (CCB), or the angiotensin converting enzyme (ACE) inhibitor lisinopril had different outcome rates with regard to six CVD phenotypes. (The doxazosin treatment arm was not included in the pharmacogenetic analyses. See below.) All three of these drugs are known to effectively lower blood pressure and all three are commonly prescribed. The effect of treatment assignment on CVD outcomes has been previously published <xref rid="pone.0023609-ALLHAT1" ref-type="bibr">[24]</xref>, <xref rid="pone.0023609-Antihypertensive1" ref-type="bibr">[25]</xref>. We sought to determine whether genotype for these variants interacted with treatment assignment to produce a pharmacogenetic association with CVD outcomes.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Ethics statement</title><p>Participants recruited during the parent Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) signed informed consent documents; the GenHAT study was approved by the University of Minnesota Institutional Review Board, the University of Alabama at Birmingham Institutional Review Board for Human Use, and the University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects.</p></sec><sec id="s2b"><title>Study Population</title><p>Study participants were part of the GenHAT study, the primary objective of which was to determine whether variants in hypertension susceptibility genes interact with antihypertensive drugs to modify coronary heart disease risk in hypertensive patients <xref rid="pone.0023609-Arnett1" ref-type="bibr">[26]</xref>. GenHAT is ancillary to the ALLHAT study, a randomized, double-blind clinical trial examining 42,418 hypertensive patients age 55 or older (47&#x00025; non-White and 46&#x00025; female) with one or more risk factors for CVD. Participants were randomized to one of four ALLHAT treatment arms&#x02014;chlorthalidone, lisinopril, amlodipine, and doxazosin, in a ratio of 1.7&#x02236;1&#x02236;1&#x02236;1, respectively <xref rid="pone.0023609-Arnett1" ref-type="bibr">[26]</xref>. Due to early discontinuation of the doxazosin arm of ALLHAT <xref rid="pone.0023609-ALLHAT2" ref-type="bibr">[27]</xref>&#x02014;and thus fewer clinical outcomes in genotype and treatment groups&#x02014;we have not included the doxazosin group in these analyses. The drug doses were titrated to achieve blood pressures lower than 140/90 mmHg. Detailed descriptions of both ALLHAT and GenHAT have been published elsewhere <xref rid="pone.0023609-Arnett1" ref-type="bibr">[26]</xref>, <xref rid="pone.0023609-Davis1" ref-type="bibr">[28]</xref>.</p><p>GenHAT genotyped variants in several hypertension-related genes in the 39,114 ALLHAT participants with available DNA, making the study design a post-hoc subgroup analysis of a randomized clinical trial <xref rid="pone.0023609-Lynch1" ref-type="bibr">[29]</xref>. Participants were excluded from analysis if they were missing genotype data (n&#x0200a;=&#x0200a;489 for <italic>MMP9</italic> R279Q, n&#x0200a;=&#x0200a;499 for <italic>MMP9</italic> R668Q, n&#x0200a;=&#x0200a;1019 for <italic>MMP12</italic> N122S, n&#x0200a;=&#x0200a;577 for <italic>MMP12</italic> &#x02212;82A&#x0003e;G). There were 38,698 participants successfully genotyped for at least one of the polymorphisms included in this analysis.</p></sec><sec id="s2c"><title>Outcomes</title><p>The primary outcome for both ALLHAT and GenHAT was coronary heart disease (CHD), defined as fatal CHD or nonfatal myocardial infarction (MI). Secondary outcomes for this study included all-cause mortality (ACM); stroke; chronic heart failure (CHF); combined CHD outcomes (CCHD, defined as CHD death or non-fatal MI plus revascularization procedures plus hospitalized angina); and combined CVD (CCVD, defined as CHD death or non-fatal MI plus stroke, revascularization procedures, angina [in hospital or outpatient], heart failure [in hospital or outpatient], stroke, and peripheral arterial disease). Outcomes were reported by the clinical investigator and supported, when possible, by death certificates and hospitalization records. For a more detailed description of ALLHAT outcomes, see Davis et al. <xref rid="pone.0023609-Davis1" ref-type="bibr">[28]</xref>.</p></sec><sec id="s2d"><title>Genotyping</title><p>Anonymized samples containing DNA were collected on FTA paper (Fitzco Inc., Maple Plain, MN) and processed as described by Arnett et al. <xref rid="pone.0023609-Arnett1" ref-type="bibr">[26]</xref>. Genotyping was performed using a multiplex PCR and a linear immobilized probe research assay for candidate markers (Roche Molecular Systems, Pleasanton, CA, USA) as described by Burns et al. <xref rid="pone.0023609-Burns1" ref-type="bibr">[30]</xref>. GenHAT genotyped two SNPs in <italic>MMP9</italic> (R279Q, rs17576 and R668Q, rs2274756) and two SNPs in <italic>MMP12</italic> (N122S, rs652438 and &#x02212;82A&#x0003e;G, rs2276109). The polymorphisms were genotyped in the context of a larger panel of variants selected by the assay's designer as candidates for cardiovascular disease. Genotyping QC was accomplished by preparing a set of 10 trays of replicate DNA samples (n&#x0200a;=&#x0200a;767; 2&#x00025; of GenHAT cohort) which were genotyped along with the others. For the four variants reported on here, correspondence between replicate genotype calls ranged from 97.6&#x00025; to 99.1&#x00025;.</p></sec><sec id="s2e"><title>Statistical analysis</title><p>STATA version 9.2 (STATA Corporation, College Station, TX) was used for all analyses. Hardy-Weinberg equilibrium (HWE) tests were performed using chi-square tests. To test for baseline differences between treatment groups, we used ANOVA for continuous variables and chi-square tests for categorical variables. Cox proportional regression was used for testing the main effects of MMP genotypes on the outcomes as well as the genotype-by-treatment interactions (the pharmacogenetic effects), resulting in hazard ratios (HR) and ratios of hazard ratios point estimates, respectively. To test the main effects of the genotypes on the outcomes, we adjusted for age; gender; ethnicity (Hispanic status); race (5 self-reported categories: White, Black, American Indian/Alaskan native, Asian/Pacific Islander, and &#x0201c;other&#x0201d;); smoking status; diabetes status; aspirin use; and baseline values for body mass index (BMI), systolic and diastolic blood pressures, and HDL and LDL cholesterol. To test for genotype-by-treatment interactions, we created a genotype x treatment parameter and did three separate comparisons: chlorthalidone versus amlodipine, chlorthalidone versus lisinopril, and lisinopril versus amlodipine. We tested three genetic models for the pharmacogenetic effects: additive (3 genotype categories with a 2 degrees of freedom [df] interaction test), dominant (collapsing minor homozygote group with heterozygote group resulting in 2 genotype groups with a 1 df interaction test), and recessive (collapsing common homozygote group with heterozygote group resulting in 2 genotype groups with a 1 df interaction test).</p><p>The previously published GenHAT design paper outlined six primary, <italic>a priori</italic> hypotheses; however, these hypotheses did not include testing the pharmacogenetic effect of <italic>MMP9</italic> or <italic>MMP12</italic> variants. Therefore, secondary investigations such as this MMP study are considered exploratory and, as such, are not adjusted for multiple comparisons. Since we performed multiple statistical tests of the pharmacogenetic effects of <italic>MMP9</italic> and <italic>MMP12</italic> variants, caution must be exercised in pronouncing any findings reported here as statistically significant.</p></sec></sec><sec id="s3"><title>Results</title><p>
<xref ref-type="table" rid="pone-0023609-t001">Table 1</xref> shows the baseline characteristics of the study subjects (n&#x0200a;=&#x0200a;38,698, participants with at least one variant included in these analyses). There were no significant differences between groups except for HDL cholesterol (<italic>P</italic>&#x0200a;=&#x0200a;0.04), which was higher in those randomized to amlodipine versus chlorthalidone or lisinopril.</p><table-wrap id="pone-0023609-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t001</object-id><label>Table 1</label><caption><title>Baseline characteristics for participants (n&#x0200a;=&#x0200a;38,698) by treatment group, mean (SD) unless otherwise noted.</title></caption><alternatives><graphic id="pone-0023609-t001-1" xlink:href="pone.0023609.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Characteristic</td><td align="left" rowspan="1" colspan="1">Chlorthalidone</td><td align="left" rowspan="1" colspan="1">Amlodipine</td><td align="left" rowspan="1" colspan="1">Lisinopril</td><td align="left" rowspan="1" colspan="1">Doxazosin</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>-value<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref>
</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sample size, n (&#x00025;) by treatment</td><td align="left" rowspan="1" colspan="1">13,928 (36.0)</td><td align="left" rowspan="1" colspan="1">8,243 (21.3)</td><td align="left" rowspan="1" colspan="1">8,273 (21.4)</td><td align="left" rowspan="1" colspan="1">8,254 (21.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age (y)</td><td align="left" rowspan="1" colspan="1">66.8 (7.7)</td><td align="left" rowspan="1" colspan="1">66.9 (7.7)</td><td align="left" rowspan="1" colspan="1">66.8 (7.8)</td><td align="left" rowspan="1" colspan="1">66.7 (7.7)</td><td align="left" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">Race</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">White, n (col &#x00025;)</td><td align="left" rowspan="1" colspan="1">8,451 (60.7)</td><td align="left" rowspan="1" colspan="1">4,999 (60.7)</td><td align="left" rowspan="1" colspan="1">5,025 (60.7)</td><td align="left" rowspan="1" colspan="1">4,976 (60.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Black, n (col &#x00025;)</td><td align="left" rowspan="1" colspan="1">4,770 (34.3)</td><td align="left" rowspan="1" colspan="1">2,859 (34.7)</td><td align="left" rowspan="1" colspan="1">2,839 (34.3)</td><td align="left" rowspan="1" colspan="1">2,890 (35.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">American Indian/Alaskan native, n (col &#x00025;)</td><td align="left" rowspan="1" colspan="1">26 (0.2)</td><td align="left" rowspan="1" colspan="1">19 (0.2)</td><td align="left" rowspan="1" colspan="1">18 (0.2)</td><td align="left" rowspan="1" colspan="1">10 (0.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Asian/Pacific Islander, n (col &#x00025;)</td><td align="left" rowspan="1" colspan="1">170 (1.2)</td><td align="left" rowspan="1" colspan="1">97 (1.2)</td><td align="left" rowspan="1" colspan="1">85 (1.0)</td><td align="left" rowspan="1" colspan="1">95 (1.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Other, n (col &#x00025;)</td><td align="left" rowspan="1" colspan="1">511 (3.7)</td><td align="left" rowspan="1" colspan="1">269 (3.3)</td><td align="left" rowspan="1" colspan="1">306 (3.7)</td><td align="left" rowspan="1" colspan="1">283 (3.4)</td><td align="left" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" rowspan="1" colspan="1">Hispanic, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">2,722 (19.5)</td><td align="left" rowspan="1" colspan="1">1,558 (18.9)</td><td align="left" rowspan="1" colspan="1">1,639 (19.8)</td><td align="left" rowspan="1" colspan="1">1,618 (19.6)</td><td align="left" rowspan="1" colspan="1">0.86</td></tr><tr><td align="left" rowspan="1" colspan="1">Women, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">6,552 (47.0)</td><td align="left" rowspan="1" colspan="1">3,926 (47.6)</td><td align="left" rowspan="1" colspan="1">3,831 (46.3)</td><td align="left" rowspan="1" colspan="1">3,817 (46.2)</td><td align="left" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous antihypertensive treatment, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">12,571 (90.3)</td><td align="left" rowspan="1" colspan="1">7,472 (90.7)</td><td align="left" rowspan="1" colspan="1">7,454 (90.1)</td><td align="left" rowspan="1" colspan="1">7,447 (90.2)</td><td align="left" rowspan="1" colspan="1">0.66</td></tr><tr><td colspan="6" align="left" rowspan="1">Blood pressure at baseline, mm Hg</td></tr><tr><td align="left" rowspan="1" colspan="1">All participants</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;SBP</td><td align="left" rowspan="1" colspan="1">146.2 (15.7)</td><td align="left" rowspan="1" colspan="1">146.2 (15.7)</td><td align="left" rowspan="1" colspan="1">146.5 (15.6)</td><td align="left" rowspan="1" colspan="1">146.3 (15.8)</td><td align="left" rowspan="1" colspan="1">0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;DBP</td><td align="left" rowspan="1" colspan="1">84.1 (10.0)</td><td align="left" rowspan="1" colspan="1">83.9 (10.2)</td><td align="left" rowspan="1" colspan="1">84.1 (10.0)</td><td align="left" rowspan="1" colspan="1">83.9 (10.0)</td><td align="left" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" rowspan="1" colspan="1">Treated at baseline</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;SBP</td><td align="left" rowspan="1" colspan="1">145.2 (15.6)</td><td align="left" rowspan="1" colspan="1">145.1 (15.6)</td><td align="left" rowspan="1" colspan="1">145.4 (15.5)</td><td align="left" rowspan="1" colspan="1">145.2 (15.7)</td><td align="left" rowspan="1" colspan="1">0.75</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;DBP</td><td align="left" rowspan="1" colspan="1">83.5 (10.0)</td><td align="left" rowspan="1" colspan="1">83.3 (10.1)</td><td align="left" rowspan="1" colspan="1">83.6 (9.9)</td><td align="left" rowspan="1" colspan="1">83.4 (9.9)</td><td align="left" rowspan="1" colspan="1">0.30</td></tr><tr><td align="left" rowspan="1" colspan="1">Untreated at baseline</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;SBP</td><td align="left" rowspan="1" colspan="1">156.1 (12.0)</td><td align="left" rowspan="1" colspan="1">156.6 (12.2)</td><td align="left" rowspan="1" colspan="1">156.4 (12.3)</td><td align="left" rowspan="1" colspan="1">156.8 (12.5)</td><td align="left" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;DBP</td><td align="left" rowspan="1" colspan="1">89.5 (9.0)</td><td align="left" rowspan="1" colspan="1">89.7 (9.5)</td><td align="left" rowspan="1" colspan="1">89.1 (9.3)</td><td align="left" rowspan="1" colspan="1">89.4 (9.5)</td><td align="left" rowspan="1" colspan="1">0.63</td></tr><tr><td colspan="6" align="left" rowspan="1">Eligibility risk factors</td></tr><tr><td align="left" rowspan="1" colspan="1">Current cigarette smoker, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">3,061 (22.0)</td><td align="left" rowspan="1" colspan="1">1,810 (22.0)</td><td align="left" rowspan="1" colspan="1">1,817 (22.0)</td><td align="left" rowspan="1" colspan="1">1,795 (21.8)</td><td align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Type 2 diabetes, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">4,983 (35.8)</td><td align="left" rowspan="1" colspan="1">3,008 (36.5)</td><td align="left" rowspan="1" colspan="1">2,899 (35.0)</td><td align="left" rowspan="1" colspan="1">2,891 (35.0)</td><td align="left" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL cholesterol &#x0003c;35 mg/dL, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">1,666 (12.0)</td><td align="left" rowspan="1" colspan="1">939 (11.4)</td><td align="left" rowspan="1" colspan="1">976 (11.8)</td><td align="left" rowspan="1" colspan="1">973 (11.8)</td><td align="left" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" rowspan="1" colspan="1">LVH by electrocardiogram, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">2,255 (16.2)</td><td align="left" rowspan="1" colspan="1">1,398 (17.0)</td><td align="left" rowspan="1" colspan="1">1,342 (16.2)</td><td align="left" rowspan="1" colspan="1">1,354 (16.4)</td><td align="left" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td><td align="left" rowspan="1" colspan="1">29.7 (6.1)</td><td align="left" rowspan="1" colspan="1">29.8 (6.3)</td><td align="left" rowspan="1" colspan="1">29.8 (6.2)</td><td align="left" rowspan="1" colspan="1">29.7 (5.9)</td><td align="left" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting glucose, mg/dL</td><td align="left" rowspan="1" colspan="1">123.4 (58.6)</td><td align="left" rowspan="1" colspan="1">123.1 (57.5)</td><td align="left" rowspan="1" colspan="1">122.4 (55.6)</td><td align="left" rowspan="1" colspan="1">121.9 (55.9)</td><td align="left" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL cholesterol, mg/dL</td><td align="left" rowspan="1" colspan="1">136.0 (37.3)</td><td align="left" rowspan="1" colspan="1">135.7 (37.3)</td><td align="left" rowspan="1" colspan="1">135.8 (36.4)</td><td align="left" rowspan="1" colspan="1">135.2 (36.3)</td><td align="left" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL cholesterol, mg/dL</td><td align="left" rowspan="1" colspan="1">46.8 (14.9)</td><td align="left" rowspan="1" colspan="1">47.2 (14.7)</td><td align="left" rowspan="1" colspan="1">46.6 (14.6)</td><td align="left" rowspan="1" colspan="1">46.6 (14.4)</td><td align="left" rowspan="1" colspan="1">
<bold>0.04</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting triglycerides, mg/dL</td><td align="left" rowspan="1" colspan="1">176.7 (130.9)</td><td align="left" rowspan="1" colspan="1">176.6 (132.8)</td><td align="left" rowspan="1" colspan="1">175.5 (138.5)</td><td align="left" rowspan="1" colspan="1">174.1 (137.6)</td><td align="left" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Aspirin use, n (&#x00025;)</td><td align="left" rowspan="1" colspan="1">4,986 (35.8)</td><td align="left" rowspan="1" colspan="1">3,002 (36.4)</td><td align="left" rowspan="1" colspan="1">3,021 (36.5)</td><td align="left" rowspan="1" colspan="1">3,026 (36.7)</td><td align="left" rowspan="1" colspan="1">0.54</td></tr><tr><td colspan="6" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (A&#x0003e;G) (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">5,955 (42.8)</td><td align="left" rowspan="1" colspan="1">3,422 (41.6)</td><td align="left" rowspan="1" colspan="1">3,596 (43.6)</td><td align="left" rowspan="1" colspan="1">3,550 (43.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">6,257 (45.0)</td><td align="left" rowspan="1" colspan="1">3,783 (46.0)</td><td align="left" rowspan="1" colspan="1">3,633 (44.0)</td><td align="left" rowspan="1" colspan="1">3,675 (44.6)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">1,691 (12.2)</td><td align="left" rowspan="1" colspan="1">1,026 (12.5)</td><td align="left" rowspan="1" colspan="1">1,024 (12.4)</td><td align="left" rowspan="1" colspan="1">1,013 (12.3)</td><td align="left" rowspan="1" colspan="1">0.21</td></tr><tr><td colspan="6" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (G&#x0003e;A) (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">10,004 (72.0)</td><td align="left" rowspan="1" colspan="1">5,827 (70.8)</td><td align="left" rowspan="1" colspan="1">5,916 (71.7)</td><td align="left" rowspan="1" colspan="1">5,939 (72.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">3,564 (25.7)</td><td align="left" rowspan="1" colspan="1">2,196 (26.7)</td><td align="left" rowspan="1" colspan="1">2,121 (25.7)</td><td align="left" rowspan="1" colspan="1">2,085 (25.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">326 (2.4)</td><td align="left" rowspan="1" colspan="1">207 (2.5)</td><td align="left" rowspan="1" colspan="1">219 (2.7)</td><td align="left" rowspan="1" colspan="1">211 (2.6)</td><td align="left" rowspan="1" colspan="1">0.33</td></tr><tr><td colspan="6" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">11,648 (84.0)</td><td align="left" rowspan="1" colspan="1">6,899 (84.0)</td><td align="left" rowspan="1" colspan="1">6,903 (83.8)</td><td align="left" rowspan="1" colspan="1">6,926 (84.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2,083 (15.0)</td><td align="left" rowspan="1" colspan="1">1,242 (15.1)</td><td align="left" rowspan="1" colspan="1">1,269 (15.4)</td><td align="left" rowspan="1" colspan="1">1,216 (14.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">137 (1.0)</td><td align="left" rowspan="1" colspan="1">68 (0.8)</td><td align="left" rowspan="1" colspan="1">68 (0.8)</td><td align="left" rowspan="1" colspan="1">78 (1.0)</td><td align="left" rowspan="1" colspan="1">0.74</td></tr><tr><td colspan="6" align="left" rowspan="1">
<italic>MMP12</italic> N122S (A&#x0003e;G) (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">11,029 (80.6)</td><td align="left" rowspan="1" colspan="1">6,562 (80.8)</td><td align="left" rowspan="1" colspan="1">6,652 (81.5)</td><td align="left" rowspan="1" colspan="1">6,565 (80.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2,423 (17.7)</td><td align="left" rowspan="1" colspan="1">1,415 (17.4)</td><td align="left" rowspan="1" colspan="1">1,400 (17.2)</td><td align="left" rowspan="1" colspan="1">1,426 (17.6)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">235 (1.7)</td><td align="left" rowspan="1" colspan="1">145 (1.8)</td><td align="left" rowspan="1" colspan="1">111 (1.4)</td><td align="left" rowspan="1" colspan="1">132 (1.6)</td><td align="left" rowspan="1" colspan="1">0.31</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>SBP&#x0200a;=&#x0200a;systolic blood pressure, DBP&#x0200a;=&#x0200a;diastolic blood pressure, LVH&#x0200a;=&#x0200a;left ventricular hypertrophy.</p></fn><fn id="nt102"><label/><p>&#x0002a;test of differences between genotype groups: ANOVA for continuous variables, chi-square for categorical variables.</p></fn></table-wrap-foot></table-wrap><p>The <italic>MMP9</italic> R279Q and <italic>MMP12</italic> &#x02212;82A&#x0003e;G genotype frequencies were in Hardy-Weinberg equilibrium (HWE) when tested within race/ethnicity groups. The <italic>MMP9</italic> R668Q genotype frequencies were in HWE equilibrium for the Black, American Indian/Alaskan native, Asian/Pacific islander, and &#x0201c;other&#x0201d; groups, but not for the White group (<italic>P</italic>&#x0200a;=&#x0200a;0.04). After stratifying Whites by Hispanic status, the <italic>MMP9</italic> R668Q genotype frequencies were in HWE for non-Hispanic Whites, but not for Hispanic Whites (<italic>P</italic>&#x0200a;=&#x0200a;0.001). The <italic>MMP12</italic> N122S genotype frequencies were in HWE for the Asian/Pacific islander and &#x0201c;other&#x0201d; groups, but not for the Black or White groups. The American Indian/Alaskan native group included no minor <italic>MMP12</italic> N122S homozygotes (ie, GG). After stratifying Whites and Blacks by Hispanic status, <italic>MMP12</italic> N122S genotype frequencies were in HWE for all groups except Black non-Hispanics (<italic>P</italic>&#x0200a;=&#x0200a;0.0003).</p><sec id="s3a"><title>Main effects of <italic>MMP9</italic> and <italic>MMP12</italic> variants on clinical outcomes</title><p>The effects of ALLHAT treatment assignments on CVD outcomes have been published elsewhere <xref rid="pone.0023609-ALLHAT1" ref-type="bibr">[24]</xref>, <xref rid="pone.0023609-Antihypertensive1" ref-type="bibr">[25]</xref>, <xref rid="pone.0023609-ALLHAT2" ref-type="bibr">[27]</xref>. Hazard ratios for main effects of genetic variants on ALLHAT clinical outcomes in GenHAT are shown in <xref ref-type="table" rid="pone-0023609-t002">Table 2</xref>. After adjusting for baseline characteristics, the association between the <italic>MMP9</italic> R279Q variant and stroke was modestly significant, with participants carrying the minor G allele having decreased risk of stroke (HR&#x0200a;=&#x0200a;1.00 for AA, 0.87 for GA, 0.91 for GG; <italic>P</italic>&#x0200a;=&#x0200a;0.04, additive genetic model). The associations between the <italic>MMP12</italic> N122S variant and CHD and CCHD were also modestly significant (<italic>P</italic>&#x0200a;=&#x0200a;0.04 and <italic>P</italic>&#x0200a;=&#x0200a;0.01, respectively), with participants with the minor allele homozygote (GG) genotype having a 30&#x00025; increased risk of CHD or CCHD compared to participants having the common AA genotype (for CHD HR&#x0200a;=&#x0200a;1.00 for AA, 0.95 for AG, 1.36 for GG; <italic>P</italic>&#x0200a;=&#x0200a;0.04; for CCHD HR&#x0200a;=&#x0200a;1.00 for AA, 0.95 for AG, 1.31 for GG; <italic>P</italic>&#x0200a;=&#x0200a;0.01). The effects of the <italic>MMP9</italic> R668Q and <italic>MMP12</italic> &#x02212;82A&#x0003e;G variants were not significant for any outcome.</p><table-wrap id="pone-0023609-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t002</object-id><label>Table 2</label><caption><title>Main effects of MMP genetic variants on clinical outcomes, all treatments combined.</title></caption><alternatives><graphic id="pone-0023609-t002-2" xlink:href="pone.0023609.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="6" align="left" rowspan="1">Number of events (event rate per 1000 p-y)</td><td colspan="6" align="left" rowspan="1">Adjusted<xref ref-type="table-fn" rid="nt104">&#x0002a;</xref> Hazard Ratios (95&#x00025; CI)</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHD</td><td align="left" rowspan="1" colspan="1">CCHD</td><td align="left" rowspan="1" colspan="1">CCVD</td><td align="left" rowspan="1" colspan="1">ACM</td><td align="left" rowspan="1" colspan="1">Stroke</td><td align="left" rowspan="1" colspan="1">CHF</td><td align="left" rowspan="1" colspan="1">CHD</td><td align="left" rowspan="1" colspan="1">CCHD</td><td align="left" rowspan="1" colspan="1">CCVD</td><td align="left" rowspan="1" colspan="1">ACM</td><td align="left" rowspan="1" colspan="1">Stroke</td><td align="left" rowspan="1" colspan="1">CHF</td></tr></thead><tbody><tr><td colspan="13" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1373</td><td align="left" rowspan="1" colspan="1">2573</td><td align="left" rowspan="1" colspan="1">4368</td><td align="left" rowspan="1" colspan="1">2268</td><td align="left" rowspan="1" colspan="1">777</td><td align="left" rowspan="1" colspan="1">1149</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.0)</td><td align="left" rowspan="1" colspan="1">(37.3)</td><td align="left" rowspan="1" colspan="1">(68.1)</td><td align="left" rowspan="1" colspan="1">(29.0)</td><td align="left" rowspan="1" colspan="1">(10.6)</td><td align="left" rowspan="1" colspan="1">(15.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">1478</td><td align="left" rowspan="1" colspan="1">2738</td><td align="left" rowspan="1" colspan="1">4529</td><td align="left" rowspan="1" colspan="1">2319</td><td align="left" rowspan="1" colspan="1">731</td><td align="left" rowspan="1" colspan="1">1158</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.87</td><td align="left" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.5)</td><td align="left" rowspan="1" colspan="1">(37.8)</td><td align="left" rowspan="1" colspan="1">(67.2)</td><td align="left" rowspan="1" colspan="1">(28.1)</td><td align="left" rowspan="1" colspan="1">(9.5)</td><td align="left" rowspan="1" colspan="1">(15.3)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.79&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">(0.85&#x02013;1.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">420</td><td align="left" rowspan="1" colspan="1">767</td><td align="left" rowspan="1" colspan="1">1275</td><td align="left" rowspan="1" colspan="1">618</td><td align="left" rowspan="1" colspan="1">202</td><td align="left" rowspan="1" colspan="1">347</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(20.3)</td><td align="left" rowspan="1" colspan="1">(38.9)</td><td align="left" rowspan="1" colspan="1">(69.3)</td><td align="left" rowspan="1" colspan="1">(27.4)</td><td align="left" rowspan="1" colspan="1">(9.6)</td><td align="left" rowspan="1" colspan="1">(16.8)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">(0.85&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.78&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.16)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">
<bold>0.04</bold>
</td><td align="left" rowspan="1" colspan="1">0.10</td></tr><tr><td colspan="13" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2360</td><td align="left" rowspan="1" colspan="1">4376</td><td align="left" rowspan="1" colspan="1">7311</td><td align="left" rowspan="1" colspan="1">3738</td><td align="left" rowspan="1" colspan="1">1240</td><td align="left" rowspan="1" colspan="1">1897</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.6)</td><td align="left" rowspan="1" colspan="1">(38.0)</td><td align="left" rowspan="1" colspan="1">(68.3)</td><td align="left" rowspan="1" colspan="1">(28.5)</td><td align="left" rowspan="1" colspan="1">(10.2)</td><td align="left" rowspan="1" colspan="1">(15.7)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">817</td><td align="left" rowspan="1" colspan="1">1538</td><td align="left" rowspan="1" colspan="1">2579</td><td align="left" rowspan="1" colspan="1">1323</td><td align="left" rowspan="1" colspan="1">425</td><td align="left" rowspan="1" colspan="1">688</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(18.6)</td><td align="left" rowspan="1" colspan="1">(36.6)</td><td align="left" rowspan="1" colspan="1">(66.1)</td><td align="left" rowspan="1" colspan="1">(27.7)</td><td align="left" rowspan="1" colspan="1">(9.5)</td><td align="left" rowspan="1" colspan="1">(15.7)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.09)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">164</td><td align="left" rowspan="1" colspan="1">275</td><td align="left" rowspan="1" colspan="1">133</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">67</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">1.10</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(22.4)</td><td align="left" rowspan="1" colspan="1">(41.0)</td><td align="left" rowspan="1" colspan="1">(74.0)</td><td align="left" rowspan="1" colspan="1">(29.3)</td><td align="left" rowspan="1" colspan="1">(10.5)</td><td align="left" rowspan="1" colspan="1">(16.0)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.43)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.29)</td><td align="left" rowspan="1" colspan="1">(0.94&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">(0.80&#x02013;1.15)</td><td align="left" rowspan="1" colspan="1">(0.72&#x02013;1.35)</td><td align="left" rowspan="1" colspan="1">(0.77&#x02013;1.29)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="1" colspan="1">0.31</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td colspan="13" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2692</td><td align="left" rowspan="1" colspan="1">4991</td><td align="left" rowspan="1" colspan="1">8409</td><td align="left" rowspan="1" colspan="1">4409</td><td align="left" rowspan="1" colspan="1">1445</td><td align="left" rowspan="1" colspan="1">2161</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.1)</td><td align="left" rowspan="1" colspan="1">(37.0)</td><td align="left" rowspan="1" colspan="1">(67.0)</td><td align="left" rowspan="1" colspan="1">(28.7)</td><td align="left" rowspan="1" colspan="1">(10.1)</td><td align="left" rowspan="1" colspan="1">(15.3)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">535</td><td align="left" rowspan="1" colspan="1">1008</td><td align="left" rowspan="1" colspan="1">1624</td><td align="left" rowspan="1" colspan="1">736</td><td align="left" rowspan="1" colspan="1">245</td><td align="left" rowspan="1" colspan="1">449</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(20.8)</td><td align="left" rowspan="1" colspan="1">(41.4)</td><td align="left" rowspan="1" colspan="1">(71.9)</td><td align="left" rowspan="1" colspan="1">(26.5)</td><td align="left" rowspan="1" colspan="1">(9.4)</td><td align="left" rowspan="1" colspan="1">(17.5)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.85&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">(0.86&#x02013;1.15)</td><td align="left" rowspan="1" colspan="1">(0.94&#x02013;1.18)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">67</td><td align="left" rowspan="1" colspan="1">116</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.12</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">1.32</td><td align="left" rowspan="1" colspan="1">1.26</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(22.4)</td><td align="left" rowspan="1" colspan="1">(45.2)</td><td align="left" rowspan="1" colspan="1">(87.3)</td><td align="left" rowspan="1" colspan="1">(27.9)</td><td align="left" rowspan="1" colspan="1">(12.0)</td><td align="left" rowspan="1" colspan="1">(20.6)</td><td align="left" rowspan="1" colspan="1">(0.68&#x02013;1.42)</td><td align="left" rowspan="1" colspan="1">(0.77&#x02013;1.29)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.36)</td><td align="left" rowspan="1" colspan="1">(0.71&#x02013;1.32)</td><td align="left" rowspan="1" colspan="1">(0.81&#x02013;2.13)</td><td align="left" rowspan="1" colspan="1">(0.86&#x02013;1.83)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.87</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">0.36</td></tr><tr><td colspan="13" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2651</td><td align="left" rowspan="1" colspan="1">4969</td><td align="left" rowspan="1" colspan="1">8210</td><td align="left" rowspan="1" colspan="1">4143</td><td align="left" rowspan="1" colspan="1">1334</td><td align="left" rowspan="1" colspan="1">2126</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.7)</td><td align="left" rowspan="1" colspan="1">(38.7)</td><td align="left" rowspan="1" colspan="1">(68.8)</td><td align="left" rowspan="1" colspan="1">(28.4)</td><td align="left" rowspan="1" colspan="1">(9.8)</td><td align="left" rowspan="1" colspan="1">(15.8)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">503</td><td align="left" rowspan="1" colspan="1">911</td><td align="left" rowspan="1" colspan="1">1621</td><td align="left" rowspan="1" colspan="1">893</td><td align="left" rowspan="1" colspan="1">321</td><td align="left" rowspan="1" colspan="1">432</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">1.10</td><td align="left" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(17.2)</td><td align="left" rowspan="1" colspan="1">(32.4)</td><td align="left" rowspan="1" colspan="1">(61.9)</td><td align="left" rowspan="1" colspan="1">(28.2)</td><td align="left" rowspan="1" colspan="1">(10.9)</td><td align="left" rowspan="1" colspan="1">(14.9)</td><td align="left" rowspan="1" colspan="1">(0.86&#x02013;1.05)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.25)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;1.09)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">102</td><td align="left" rowspan="1" colspan="1">169</td><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">1.36</td><td align="left" rowspan="1" colspan="1">1.31</td><td align="left" rowspan="1" colspan="1">1.14</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">1.13</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(22.5)</td><td align="left" rowspan="1" colspan="1">(40.1)</td><td align="left" rowspan="1" colspan="1">(71.2)</td><td align="left" rowspan="1" colspan="1">(27.3)</td><td align="left" rowspan="1" colspan="1">(10.7)</td><td align="left" rowspan="1" colspan="1">(16.7)</td><td align="left" rowspan="1" colspan="1">(1.04&#x02013;1.79)</td><td align="left" rowspan="1" colspan="1">(1.06&#x02013;1.62)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.34)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.20)</td><td align="left" rowspan="1" colspan="1">(0.68&#x02013;1.49)</td><td align="left" rowspan="1" colspan="1">(0.83&#x02013;1.55)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>0.04</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.01</bold>
</td><td align="left" rowspan="1" colspan="1">0.12</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.64</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>CHD, coronary heart disease defined as fatal CHD or nonfatal myocardial infarction; CCHD, combined CHD defined as CHD death or non-fatal myocardial infarction plus revascularization procedures plus hospitalized angina; CCVD, combined cardiovascular disease defined as CHD death or non-fatal MI plus stroke, revascularization procedures, angina, heart failure, stroke, and peripheral arterial disease; ACM, all-cause mortality; CHF, .chronic heart failure.</p></fn><fn id="nt104"><label/><p>&#x0002a;adjusted for age, sex, race, Hispanic status, smoking status, diabetes status, aspirin use, and baseline values for BMI, SBP, DBP, HDL- and LDL-cholesterol.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Pharmacogenetic effects of <italic>MMP9</italic> and <italic>MMP12</italic> variants on clinical outcomes</title><p>
<xref ref-type="table" rid="pone-0023609-t003">Tables 3</xref>, <xref ref-type="table" rid="pone-0023609-t004">4</xref>, <xref ref-type="table" rid="pone-0023609-t005">5</xref>, <xref ref-type="table" rid="pone-0023609-t006">6</xref>, <xref ref-type="table" rid="pone-0023609-t007">7</xref>, <xref ref-type="table" rid="pone-0023609-t008">8</xref> show ALLHAT clinical outcome frequencies and rates by genotype and treatment group for CHD, CCHD, CCVD, ACM, stroke, and CHF, respectively. Also shown are genotype-specific treatment effects and gene-by-treatment interaction <italic>P</italic>-values for chlorthalidone versus amlodipine, chlorthalidone versus lisinopril, and lisinopril versus amlodipine. Treatment effects differed by genotype for several outcomes.</p><table-wrap id="pone-0023609-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t003</object-id><label>Table 3</label><caption><title>Pharmacogenetic effects of MMP genetic variants on CHD.</title></caption><alternatives><graphic id="pone-0023609-t003-3" xlink:href="pone.0023609.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Number of events (Event rate per 1000 p-y)</td><td colspan="3" align="left" rowspan="1">Genotype-specific treatment effects (Hazard Ratio (95&#x00025; CI))</td><td colspan="3" align="left" rowspan="1">Pharmacogenetic effects<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHL</td><td align="left" rowspan="1" colspan="1">AML</td><td align="left" rowspan="1" colspan="1">LIS</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">544</td><td align="left" rowspan="1" colspan="1">285</td><td align="left" rowspan="1" colspan="1">311</td><td align="left" rowspan="1" colspan="1">1.12</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.11</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.18</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.56</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(20.0)</td><td align="left" rowspan="1" colspan="1">(17.9)</td><td align="left" rowspan="1" colspan="1">(18.9)</td><td align="left" rowspan="1" colspan="1">(0.97&#x02013;1.29)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.24)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">550</td><td align="left" rowspan="1" colspan="1">343</td><td align="left" rowspan="1" colspan="1">307</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.07</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.39</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.38</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.0)</td><td align="left" rowspan="1" colspan="1">(19.7)</td><td align="left" rowspan="1" colspan="1">(18.5)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1">(0.81&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">137</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">101</td><td align="left" rowspan="1" colspan="1">0.84</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.13</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.07</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.78</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(17.7)</td><td align="left" rowspan="1" colspan="1">(21.1)</td><td align="left" rowspan="1" colspan="1">(22.0)</td><td align="left" rowspan="1" colspan="1">(0.65&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.62&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">(0.79&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">902</td><td align="left" rowspan="1" colspan="1">523</td><td align="left" rowspan="1" colspan="1">517</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.13</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.45</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.61</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.7)</td><td align="left" rowspan="1" colspan="1">(19.5)</td><td align="left" rowspan="1" colspan="1">(19.2)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">303</td><td align="left" rowspan="1" colspan="1">177</td><td align="left" rowspan="1" colspan="1">180</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.97</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.53</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.60</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(18.3)</td><td align="left" rowspan="1" colspan="1">(17.2)</td><td align="left" rowspan="1" colspan="1">(18.6)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.29)</td><td align="left" rowspan="1" colspan="1">(0.82&#x02013;1.19)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.33)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">0.84</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.05</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.22</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.50</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(16.9)</td><td align="left" rowspan="1" colspan="1">(28.5)</td><td align="left" rowspan="1" colspan="1">(23.8)</td><td align="left" rowspan="1" colspan="1">(0.34&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.42&#x02013;1.30)</td><td align="left" rowspan="1" colspan="1">(0.48&#x02013;1.46)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1006</td><td align="left" rowspan="1" colspan="1">610</td><td align="left" rowspan="1" colspan="1">591</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.52</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.19</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.13</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(18.8)</td><td align="left" rowspan="1" colspan="1">(19.2)</td><td align="left" rowspan="1" colspan="1">(18.8)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">200</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">125</td><td align="left" rowspan="1" colspan="1">1.14</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.25</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.77</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.44</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(20.9)</td><td align="left" rowspan="1" colspan="1">(18.4)</td><td align="left" rowspan="1" colspan="1">(21.3)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.44)</td><td align="left" rowspan="1" colspan="1">(0.79&#x02013;1.23)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.50)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">3.25</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.96</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.07</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.10</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(28.9)</td><td align="left" rowspan="1" colspan="1">(28.3)</td><td align="left" rowspan="1" colspan="1">(9.3)</td><td align="left" rowspan="1" colspan="1">(0.45&#x02013;2.22)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;11.0)</td><td align="left" rowspan="1" colspan="1">(0.09&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1003</td><td align="left" rowspan="1" colspan="1">593</td><td align="left" rowspan="1" colspan="1">563</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.91</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.005</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.041</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.8)</td><td align="left" rowspan="1" colspan="1">(19.6)</td><td align="left" rowspan="1" colspan="1">(18.5)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">(0.97&#x02013;1.19)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">182</td><td align="left" rowspan="1" colspan="1">113</td><td align="left" rowspan="1" colspan="1">128</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">1.19</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.66</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.005</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.037</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(16.3)</td><td align="left" rowspan="1" colspan="1">(17.0)</td><td align="left" rowspan="1" colspan="1">(20.3)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">(0.64&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.54)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.49</td><td align="left" rowspan="1" colspan="1">1.93</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.89</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.019</bold>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(19.7)</td><td align="left" rowspan="1" colspan="1">(20.6)</td><td align="left" rowspan="1" colspan="1">(40.9)</td><td align="left" rowspan="1" colspan="1">(0.48&#x02013;1.93)</td><td align="left" rowspan="1" colspan="1">(0.26&#x02013;0.91)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;3.92)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><label/><p>
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for additive genetic model, <italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for dominant genetic model, <italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for recessive genetic model.</p></fn><fn id="nt106"><label/><p>&#x0002a;<italic>P</italic>-value for gene-by-treatment interaction.</p></fn><fn id="nt107"><label/><p>CHD, coronary heart disease defined as fatal CHD or nonfatal myocardial infarction; CHL, chlorthalidone treatment group; AML, amlodipine treatment group; LIS, lisinopril treatment group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0023609-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t004</object-id><label>Table 4</label><caption><title>Pharmacogenetic effects of MMP genetic variants on CCHD.</title></caption><alternatives><graphic id="pone-0023609-t004-4" xlink:href="pone.0023609.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Number of events (event rate per 1000 p-y)</td><td colspan="3" align="left" rowspan="1">Genotype-specific treatment effects: Hazard Ratio (95&#x00025; CI)</td><td colspan="3" align="left" rowspan="1">Pharmacogenetic effects<xref ref-type="table-fn" rid="nt109">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHL</td><td align="left" rowspan="1" colspan="1">AML</td><td align="left" rowspan="1" colspan="1">LIS</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">952</td><td align="left" rowspan="1" colspan="1">556</td><td align="left" rowspan="1" colspan="1">569</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.22</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.12</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.71</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(36.5)</td><td align="left" rowspan="1" colspan="1">(36.6)</td><td align="left" rowspan="1" colspan="1">(36.3)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">1022</td><td align="left" rowspan="1" colspan="1">602</td><td align="left" rowspan="1" colspan="1">599</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.91</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.29</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.40</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(37.2)</td><td align="left" rowspan="1" colspan="1">(36.1)</td><td align="left" rowspan="1" colspan="1">(38.1)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.94&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">256</td><td align="left" rowspan="1" colspan="1">182</td><td align="left" rowspan="1" colspan="1">186</td><td align="left" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.09</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.045</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.78</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(34.5)</td><td align="left" rowspan="1" colspan="1">(40.6)</td><td align="left" rowspan="1" colspan="1">(42.9)</td><td align="left" rowspan="1" colspan="1">(0.70&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">(0.67&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">(0.86&#x02013;1.30)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">1615</td><td align="left" rowspan="1" colspan="1">946</td><td align="left" rowspan="1" colspan="1">970</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.12</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.30</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.84</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(36.9)</td><td align="left" rowspan="1" colspan="1">(36.9)</td><td align="left" rowspan="1" colspan="1">(37.9)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.05)</td><td align="left" rowspan="1" colspan="1">(0.94&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">565</td><td align="left" rowspan="1" colspan="1">350</td><td align="left" rowspan="1" colspan="1">346</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.65</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.54</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.89</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(35.9)</td><td align="left" rowspan="1" colspan="1">(35.7)</td><td align="left" rowspan="1" colspan="1">(37.6)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.15)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.038</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.13</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.60</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(31.6)</td><td align="left" rowspan="1" colspan="1">(49.2)</td><td align="left" rowspan="1" colspan="1">(45.4)</td><td align="left" rowspan="1" colspan="1">(0.42&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">(0.47&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.61&#x02013;1.42)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1817</td><td align="left" rowspan="1" colspan="1">1109</td><td align="left" rowspan="1" colspan="1">1120</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.48</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.18</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.76</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(35.5)</td><td align="left" rowspan="1" colspan="1">(36.5)</td><td align="left" rowspan="1" colspan="1">(37.6)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.05)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">370</td><td align="left" rowspan="1" colspan="1">218</td><td align="left" rowspan="1" colspan="1">226</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.35</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.31</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.95</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(40.8)</td><td align="left" rowspan="1" colspan="1">(39.3)</td><td align="left" rowspan="1" colspan="1">(40.8)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.23)</td><td align="left" rowspan="1" colspan="1">(0.85&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1">(0.86&#x02013;1.25)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">1.35</td><td align="left" rowspan="1" colspan="1">1.91</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.33</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.08</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.46</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(54.1)</td><td align="left" rowspan="1" colspan="1">(39.4)</td><td align="left" rowspan="1" colspan="1">(29.1)</td><td align="left" rowspan="1" colspan="1">(0.70&#x02013;2.63)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;4.01)</td><td align="left" rowspan="1" colspan="1">(0.30&#x02013;1.71)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1831</td><td align="left" rowspan="1" colspan="1">1092</td><td align="left" rowspan="1" colspan="1">1092</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.45</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.023</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.14</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(38.0)</td><td align="left" rowspan="1" colspan="1">(37.8)</td><td align="left" rowspan="1" colspan="1">(37.8)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">319</td><td align="left" rowspan="1" colspan="1">209</td><td align="left" rowspan="1" colspan="1">227</td><td align="left" rowspan="1" colspan="1">0.90</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.39</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.008</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.10</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(29.7)</td><td align="left" rowspan="1" colspan="1">(32.9)</td><td align="left" rowspan="1" colspan="1">(37.7)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1">(0.66&#x02013;0.93)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.38)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">1.58</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.52</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.29</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.14</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(39.1)</td><td align="left" rowspan="1" colspan="1">(33.1)</td><td align="left" rowspan="1" colspan="1">(53.5)</td><td align="left" rowspan="1" colspan="1">(0.69&#x02013;2.01)</td><td align="left" rowspan="1" colspan="1">(0.45&#x02013;1.23)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;2.85)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt108"><label/><p>
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for additive genetic model, <italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for dominant genetic model, <italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for recessive genetic model.</p></fn><fn id="nt109"><label/><p>&#x0002a;<italic>P</italic>-value for gene-by-treatment interaction.</p></fn><fn id="nt110"><label/><p>CCHD, combined CHD defined as CHD death or non-fatal myocardial infarction plus revascularization procedures plus hospitalized angina; CHL, chlorthalidone treatment group; AML, amlodipine treatment group; LIS, lisinopril treatment group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0023609-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t005</object-id><label>Table 5</label><caption><title>Pharmacogenetic effects of MMP genetic variants on CCVD.</title></caption><alternatives><graphic id="pone-0023609-t005-5" xlink:href="pone.0023609.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Number of events (event rate per 1000 p-y)</td><td colspan="3" align="left" rowspan="1">Genotype-specific treatment effects: Hazard Ratio (95&#x00025; CI)</td><td colspan="3" align="left" rowspan="1">Pharmacogenetic effects<xref ref-type="table-fn" rid="nt112">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHL</td><td align="left" rowspan="1" colspan="1">AML</td><td align="left" rowspan="1" colspan="1">LIS</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1552</td><td align="left" rowspan="1" colspan="1">952</td><td align="left" rowspan="1" colspan="1">963</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.038</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.05</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.15</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(63.5)</td><td align="left" rowspan="1" colspan="1">(67.6)</td><td align="left" rowspan="1" colspan="1">(66.2)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;1.02)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">1631</td><td align="left" rowspan="1" colspan="1">978</td><td align="left" rowspan="1" colspan="1">1012</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">1.11</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.67</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.10</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.06</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(63.4)</td><td align="left" rowspan="1" colspan="1">(62.9)</td><td align="left" rowspan="1" colspan="1">(70.0)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;0.98)</td><td align="left" rowspan="1" colspan="1">(1.02&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">413</td><td align="left" rowspan="1" colspan="1">301</td><td align="left" rowspan="1" colspan="1">303</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.024</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.026</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.98</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(58.8)</td><td align="left" rowspan="1" colspan="1">(72.5)</td><td align="left" rowspan="1" colspan="1">(75.7)</td><td align="left" rowspan="1" colspan="1">(0.70&#x02013;0.94)</td><td align="left" rowspan="1" colspan="1">(0.67&#x02013;0.90)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2602</td><td align="left" rowspan="1" colspan="1">1600</td><td align="left" rowspan="1" colspan="1">1617</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.36</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.33</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.16</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(63.4)</td><td align="left" rowspan="1" colspan="1">(67.3)</td><td align="left" rowspan="1" colspan="1">(68.1)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.00)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;0.99)</td><td align="left" rowspan="1" colspan="1">(0.94&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">907</td><td align="left" rowspan="1" colspan="1">562</td><td align="left" rowspan="1" colspan="1">597</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.87</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.52</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.17</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(61.4)</td><td align="left" rowspan="1" colspan="1">(61.3)</td><td align="left" rowspan="1" colspan="1">(70.9)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">(0.78&#x02013;0.96)</td><td align="left" rowspan="1" colspan="1">(1.03&#x02013;1.29)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.28</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.35</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.88</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(61.9)</td><td align="left" rowspan="1" colspan="1">(77.4)</td><td align="left" rowspan="1" colspan="1">(78.9)</td><td align="left" rowspan="1" colspan="1">(0.58&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">(0.56&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1">(0.73&#x02013;1.44)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2942</td><td align="left" rowspan="1" colspan="1">1857</td><td align="left" rowspan="1" colspan="1">1890</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">0.90</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.21</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.06</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.35</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(61.3)</td><td align="left" rowspan="1" colspan="1">(65.7)</td><td align="left" rowspan="1" colspan="1">(68.6)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;0.99)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1">(0.98&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">588</td><td align="left" rowspan="1" colspan="1">343</td><td align="left" rowspan="1" colspan="1">371</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">1.10</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.08</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.16</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.74</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(69.4)</td><td align="left" rowspan="1" colspan="1">(66.2)</td><td align="left" rowspan="1" colspan="1">(72.8)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.20)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.27)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1">1.75</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.41</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.025</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.19</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(100.8)</td><td align="left" rowspan="1" colspan="1">(85.9)</td><td align="left" rowspan="1" colspan="1">(59.0)</td><td align="left" rowspan="1" colspan="1">(0.71&#x02013;1.90)</td><td align="left" rowspan="1" colspan="1">(1.01&#x02013;3.02)</td><td align="left" rowspan="1" colspan="1">(0.37&#x02013;1.31)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2903</td><td align="left" rowspan="1" colspan="1">1800</td><td align="left" rowspan="1" colspan="1">1822</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.52</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.06</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.19</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(64.2)</td><td align="left" rowspan="1" colspan="1">(67.1)</td><td align="left" rowspan="1" colspan="1">(68.3)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.00)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">566</td><td align="left" rowspan="1" colspan="1">350</td><td align="left" rowspan="1" colspan="1">388</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.76</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.024</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.08</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(56.3)</td><td align="left" rowspan="1" colspan="1">(58.8)</td><td align="left" rowspan="1" colspan="1">(69.5)</td><td align="left" rowspan="1" colspan="1">(0.84&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">(0.71&#x02013;0.92)</td><td align="left" rowspan="1" colspan="1">(1.02&#x02013;1.36)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="1" colspan="1">1.10</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.25</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.19</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.83</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(60.9)</td><td align="left" rowspan="1" colspan="1">(80.2)</td><td align="left" rowspan="1" colspan="1">(88.6)</td><td align="left" rowspan="1" colspan="1">(0.52&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1">(0.46&#x02013;1.05)</td><td align="left" rowspan="1" colspan="1">(0.71&#x02013;1.71)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt111"><label/><p>
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for additive genetic model, <italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for dominant genetic model, <italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for recessive genetic model.</p></fn><fn id="nt112"><label/><p>&#x0002a;<italic>P</italic>-value for gene-by-treatment interaction.</p></fn><fn id="nt113"><label/><p>CCVD, combined cardiovascular disease defined as CHD death or non-fatal MI plus stroke, revascularization procedures, angina, heart failure, stroke, and peripheral arterial disease; CHL, chlorthalidone treatment group; AML, amlodipine treatment group; LIS, lisinopril treatment group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0023609-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t006</object-id><label>Table 6</label><caption><title>Pharmacogenetic effects of MMP genetic variants on ACM.</title></caption><alternatives><graphic id="pone-0023609-t006-6" xlink:href="pone.0023609.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Number of events (event rate per 1000 p-y)</td><td colspan="3" align="left" rowspan="1">Genotype-specific treatment effects: Hazard Ratio (95&#x00025; CI)</td><td colspan="3" align="left" rowspan="1">Pharmacogenetic effects<xref ref-type="table-fn" rid="nt115">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHL</td><td align="left" rowspan="1" colspan="1">AML</td><td align="left" rowspan="1" colspan="1">LIS</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">858</td><td align="left" rowspan="1" colspan="1">465</td><td align="left" rowspan="1" colspan="1">519</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.72</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.87</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.76</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(29.6)</td><td align="left" rowspan="1" colspan="1">(27.5)</td><td align="left" rowspan="1" colspan="1">(29.5)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">883</td><td align="left" rowspan="1" colspan="1">510</td><td align="left" rowspan="1" colspan="1">526</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.53</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.67</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.85</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(28.6)</td><td align="left" rowspan="1" colspan="1">(27.5)</td><td align="left" rowspan="1" colspan="1">(29.6)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.16)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">229</td><td align="left" rowspan="1" colspan="1">141</td><td align="left" rowspan="1" colspan="1">138</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.50</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.87</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.46</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(27.6)</td><td align="left" rowspan="1" colspan="1">(28.0)</td><td align="left" rowspan="1" colspan="1">(27.6)</td><td align="left" rowspan="1" colspan="1">(0.79&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">(0.81&#x02013;1.24)</td><td align="left" rowspan="1" colspan="1">(0.77&#x02013;1.24)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">1420</td><td align="left" rowspan="1" colspan="1">790</td><td align="left" rowspan="1" colspan="1">859</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.97</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.83</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.81</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(29.1)</td><td align="left" rowspan="1" colspan="1">(27.6)</td><td align="left" rowspan="1" colspan="1">(29.8)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.15)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">(0.98&#x02013;1.19)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">501</td><td align="left" rowspan="1" colspan="1">294</td><td align="left" rowspan="1" colspan="1">291</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.94</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.54</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.55</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(28.4)</td><td align="left" rowspan="1" colspan="1">(27.0)</td><td align="left" rowspan="1" colspan="1">(27.8)</td><td align="left" rowspan="1" colspan="1">(0.91&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1">(0.87&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.81</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.87</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.71</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(30.0)</td><td align="left" rowspan="1" colspan="1">(30.1)</td><td align="left" rowspan="1" colspan="1">(29.7)</td><td align="left" rowspan="1" colspan="1">(0.63&#x02013;1.57)</td><td align="left" rowspan="1" colspan="1">(0.67&#x02013;1.66)</td><td align="left" rowspan="1" colspan="1">(0.58&#x02013;1.58)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1646</td><td align="left" rowspan="1" colspan="1">951</td><td align="left" rowspan="1" colspan="1">1008</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">1.07</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.17</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.19</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.12</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(28.9)</td><td align="left" rowspan="1" colspan="1">(28.1)</td><td align="left" rowspan="1" colspan="1">(29.9)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">(0.89&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">(0.98&#x02013;1.16)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">297</td><td align="left" rowspan="1" colspan="1">148</td><td align="left" rowspan="1" colspan="1">168</td><td align="left" rowspan="1" colspan="1">1.22</td><td align="left" rowspan="1" colspan="1">1.09</td><td align="left" rowspan="1" colspan="1">1.12</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.19</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.15</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.94</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(29.1)</td><td align="left" rowspan="1" colspan="1">(24.0)</td><td align="left" rowspan="1" colspan="1">(26.9)</td><td align="left" rowspan="1" colspan="1">(1.00&#x02013;1.49)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.32)</td><td align="left" rowspan="1" colspan="1">(0.90&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">2.04</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.31</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.16</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.043</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(30.8)</td><td align="left" rowspan="1" colspan="1">(42.1)</td><td align="left" rowspan="1" colspan="1">(15.1)</td><td align="left" rowspan="1" colspan="1">(0.37&#x02013;1.45)</td><td align="left" rowspan="1" colspan="1">(0.77&#x02013;5.42)</td><td align="left" rowspan="1" colspan="1">(0.13&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">1540</td><td align="left" rowspan="1" colspan="1">909</td><td align="left" rowspan="1" colspan="1">926</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.021</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.23</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.013</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(28.5)</td><td align="left" rowspan="1" colspan="1">(28.3)</td><td align="left" rowspan="1" colspan="1">(28.5)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">365</td><td align="left" rowspan="1" colspan="1">164</td><td align="left" rowspan="1" colspan="1">220</td><td align="left" rowspan="1" colspan="1">1.32</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">1.39</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.022</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.33</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.004</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(30.7)</td><td align="left" rowspan="1" colspan="1">(23.3)</td><td align="left" rowspan="1" colspan="1">(32.3)</td><td align="left" rowspan="1" colspan="1">(1.10&#x02013;1.59)</td><td align="left" rowspan="1" colspan="1">(0.80&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">(1.14&#x02013;1.71)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">1.28</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.35</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.11</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.52</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(24.8)</td><td align="left" rowspan="1" colspan="1">(30.9)</td><td align="left" rowspan="1" colspan="1">(39.6)</td><td align="left" rowspan="1" colspan="1">(0.47&#x02013;1.42)</td><td align="left" rowspan="1" colspan="1">(0.36&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">(0.70&#x02013;2.32)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt114"><label/><p>
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for additive genetic model, <italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for dominant genetic model, <italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for recessive genetic model.</p></fn><fn id="nt115"><label/><p>&#x0002a;<italic>P</italic>-value for gene-by-treatment interaction.</p></fn><fn id="nt116"><label/><p>ACM, all-cause mortality; CHL, chlorthalidone treatment group; AML, amlodipine treatment group; LIS, lisinopril treatment group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0023609-t007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t007</object-id><label>Table 7</label><caption><title>Pharmacogenetic effects of MMP genetic variants on stroke.</title></caption><alternatives><graphic id="pone-0023609-t007-7" xlink:href="pone.0023609.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Number of events (event rate per 1000 p-y)</td><td colspan="3" align="left" rowspan="1">Genotype-specific treatment effects: Hazard Ratio (95&#x00025; CI)</td><td colspan="3" align="left" rowspan="1">Pharmacogenetic effects<xref ref-type="table-fn" rid="nt118">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHL</td><td align="left" rowspan="1" colspan="1">AML</td><td align="left" rowspan="1" colspan="1">LIS</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">288</td><td align="left" rowspan="1" colspan="1">146</td><td align="left" rowspan="1" colspan="1">180</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.63</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.29</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.47</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(10.4)</td><td align="left" rowspan="1" colspan="1">(9.0)</td><td align="left" rowspan="1" colspan="1">(10.8)</td><td align="left" rowspan="1" colspan="1">(0.94&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1">(0.80&#x02013;1.16)</td><td align="left" rowspan="1" colspan="1">(0.96&#x02013;1.49)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">253</td><td align="left" rowspan="1" colspan="1">145</td><td align="left" rowspan="1" colspan="1">185</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">1.35</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.41</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.18</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.68</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(8.6)</td><td align="left" rowspan="1" colspan="1">(8.2)</td><td align="left" rowspan="1" colspan="1">(11.1)</td><td align="left" rowspan="1" colspan="1">(0.86&#x02013;1.29)</td><td align="left" rowspan="1" colspan="1">(0.65&#x02013;0.94)</td><td align="left" rowspan="1" colspan="1">(1.08&#x02013;1.67)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">1.02</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.46</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.75</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.34</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(8.9)</td><td align="left" rowspan="1" colspan="1">(9.4)</td><td align="left" rowspan="1" colspan="1">(9.6)</td><td align="left" rowspan="1" colspan="1">(0.65&#x02013;1.38)</td><td align="left" rowspan="1" colspan="1">(0.64&#x02013;1.35)</td><td align="left" rowspan="1" colspan="1">(0.68&#x02013;1.55)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">456</td><td align="left" rowspan="1" colspan="1">247</td><td align="left" rowspan="1" colspan="1">286</td><td align="left" rowspan="1" colspan="1">1.08</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.12</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.16</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.15</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(9.8)</td><td align="left" rowspan="1" colspan="1">(9.1)</td><td align="left" rowspan="1" colspan="1">(10.5)</td><td align="left" rowspan="1" colspan="1">(0.93&#x02013;1.26)</td><td align="left" rowspan="1" colspan="1">(0.81&#x02013;1.08)</td><td align="left" rowspan="1" colspan="1">(0.98&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">139</td><td align="left" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">114</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">1.39</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.99</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.10</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.15</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(8.3)</td><td align="left" rowspan="1" colspan="1">(8.4)</td><td align="left" rowspan="1" colspan="1">(11.6)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.30)</td><td align="left" rowspan="1" colspan="1">(0.56&#x02013;0.92)</td><td align="left" rowspan="1" colspan="1">(1.05&#x02013;1.84)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">3.65</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">3.50</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.048</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.62</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.11</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(11.3)</td><td align="left" rowspan="1" colspan="1">(3.1)</td><td align="left" rowspan="1" colspan="1">(10.7)</td><td align="left" rowspan="1" colspan="1">(1.07&#x02013;12.5)</td><td align="left" rowspan="1" colspan="1">(0.49&#x02013;2.23)</td><td align="left" rowspan="1" colspan="1">(0.98&#x02013;12.6)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">507</td><td align="left" rowspan="1" colspan="1">283</td><td align="left" rowspan="1" colspan="1">356</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">1.28</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.42</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.18</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.29</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(9.3)</td><td align="left" rowspan="1" colspan="1">(8.8)</td><td align="left" rowspan="1" colspan="1">(11.2)</td><td align="left" rowspan="1" colspan="1">(0.92&#x02013;1.23)</td><td align="left" rowspan="1" colspan="1">(0.73&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1">(1.10&#x02013;1.50)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">1.25</td><td align="left" rowspan="1" colspan="1">1.14</td><td align="left" rowspan="1" colspan="1">1.09</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.57</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.07</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.29</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(10.1)</td><td align="left" rowspan="1" colspan="1">(8.1)</td><td align="left" rowspan="1" colspan="1">(8.9)</td><td align="left" rowspan="1" colspan="1">(0.88&#x02013;1.76)</td><td align="left" rowspan="1" colspan="1">(0.82&#x02013;1.60)</td><td align="left" rowspan="1" colspan="1">(0.74&#x02013;1.62)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">1.58</td><td align="left" rowspan="1" colspan="1">0.43</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.31</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.50</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.16</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(9.2)</td><td align="left" rowspan="1" colspan="1">(15.8)</td><td align="left" rowspan="1" colspan="1">(6.1)</td><td align="left" rowspan="1" colspan="1">(0.18&#x02013;1.94)</td><td align="left" rowspan="1" colspan="1">(0.32&#x02013;7.81)</td><td align="left" rowspan="1" colspan="1">(0.08&#x02013;2.25)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">483</td><td align="left" rowspan="1" colspan="1">261</td><td align="left" rowspan="1" colspan="1">315</td><td align="left" rowspan="1" colspan="1">1.10</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.62</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.40</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.43</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(9.4)</td><td align="left" rowspan="1" colspan="1">(8.5)</td><td align="left" rowspan="1" colspan="1">(10.2)</td><td align="left" rowspan="1" colspan="1">(0.95&#x02013;1.28)</td><td align="left" rowspan="1" colspan="1">(0.80&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">(1.02&#x02013;1.42)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">83</td><td align="left" rowspan="1" colspan="1">1.04</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">1.41</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.56</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.22</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.60</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(9.7)</td><td align="left" rowspan="1" colspan="1">(9.3)</td><td align="left" rowspan="1" colspan="1">(13.1)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.42)</td><td align="left" rowspan="1" colspan="1">(0.56&#x02013;0.99)</td><td align="left" rowspan="1" colspan="1">(1.01&#x02013;1.96)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">1.01</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.36</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.80</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.32</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(10.2)</td><td align="left" rowspan="1" colspan="1">(14.2)</td><td align="left" rowspan="1" colspan="1">(10.1)</td><td align="left" rowspan="1" colspan="1">(0.30&#x02013;1.74)</td><td align="left" rowspan="1" colspan="1">(0.35&#x02013;2.91)</td><td align="left" rowspan="1" colspan="1">(0.24&#x02013;2.11)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt117"><label/><p>
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for additive genetic model, <italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for dominant genetic model, <italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for recessive genetic model.</p></fn><fn id="nt118"><label/><p>&#x0002a;<italic>P</italic>-value for gene-by-treatment interaction.</p></fn><fn id="nt119"><label/><p>CHL, chlorthalidone treatment group; AML, amlodipine treatment group; LIS, lisinopril treatment group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0023609-t008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0023609.t008</object-id><label>Table 8</label><caption><title>Pharmacogenetic effects of MMP genetic variants on CHF.</title></caption><alternatives><graphic id="pone-0023609-t008-8" xlink:href="pone.0023609.t008"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Number of events (event rate per 1000 p-y)</td><td colspan="3" align="left" rowspan="1">Genotype-specific treatment effects: Hazard Ratio (95&#x00025; CI)</td><td colspan="3" align="left" rowspan="1">Pharmacogenetic effects<xref ref-type="table-fn" rid="nt121">&#x0002a;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">CHL</td><td align="left" rowspan="1" colspan="1">AML</td><td align="left" rowspan="1" colspan="1">LIS</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td><td align="left" rowspan="1" colspan="1">C vs. A</td><td align="left" rowspan="1" colspan="1">C. vs. L</td><td align="left" rowspan="1" colspan="1">L vs. A</td></tr></thead><tbody><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R279Q (rs17576)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">359</td><td align="left" rowspan="1" colspan="1">283</td><td align="left" rowspan="1" colspan="1">239</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.90</td><td align="left" rowspan="1" colspan="1">0.82</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.53</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.41</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.29</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(13.1)</td><td align="left" rowspan="1" colspan="1">(17.8)</td><td align="left" rowspan="1" colspan="1">(14.5)</td><td align="left" rowspan="1" colspan="1">(0.63&#x02013;0.86)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.06)</td><td align="left" rowspan="1" colspan="1">(0.69&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">346</td><td align="left" rowspan="1" colspan="1">281</td><td align="left" rowspan="1" colspan="1">255</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.77</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.68</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.20</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.38</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(11.9)</td><td align="left" rowspan="1" colspan="1">(16.2)</td><td align="left" rowspan="1" colspan="1">(15.5)</td><td align="left" rowspan="1" colspan="1">(0.63&#x02013;0.86)</td><td align="left" rowspan="1" colspan="1">(0.65&#x02013;0.90)</td><td align="left" rowspan="1" colspan="1">(0.80&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">0.82</td><td align="left" rowspan="1" colspan="1">0.75</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.26</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.92</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.35</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(12.4)</td><td align="left" rowspan="1" colspan="1">(20.2)</td><td align="left" rowspan="1" colspan="1">(15.2)</td><td align="left" rowspan="1" colspan="1">(0.46&#x02013;0.81)</td><td align="left" rowspan="1" colspan="1">(0.60&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">(0.55&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP9</italic> R668Q (rs2274756)</td></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">591</td><td align="left" rowspan="1" colspan="1">463</td><td align="left" rowspan="1" colspan="1">403</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1">0.87</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.57</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.59</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.76</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(12.8)</td><td align="left" rowspan="1" colspan="1">(17.3)</td><td align="left" rowspan="1" colspan="1">(15.0)</td><td align="left" rowspan="1" colspan="1">(0.65&#x02013;0.83)</td><td align="left" rowspan="1" colspan="1">(0.75&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;0.99)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">192</td><td align="left" rowspan="1" colspan="1">175</td><td align="left" rowspan="1" colspan="1">149</td><td align="left" rowspan="1" colspan="1">0.67</td><td align="left" rowspan="1" colspan="1">0.75</td><td align="left" rowspan="1" colspan="1">0.90</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.34</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.33</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.93</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(11.5)</td><td align="left" rowspan="1" colspan="1">(17.2)</td><td align="left" rowspan="1" colspan="1">(15.4)</td><td align="left" rowspan="1" colspan="1">(0.55&#x02013;0.82)</td><td align="left" rowspan="1" colspan="1">(0.60&#x02013;0.93)</td><td align="left" rowspan="1" colspan="1">(0.72&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">0.57</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.69</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.49</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.97</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.49</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(11.5)</td><td align="left" rowspan="1" colspan="1">(20.1)</td><td align="left" rowspan="1" colspan="1">(13.8)</td><td align="left" rowspan="1" colspan="1">(0.30&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">(0.41&#x02013;1.68)</td><td align="left" rowspan="1" colspan="1">(0.35&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> &#x02212;82A&#x0003e;G (rs2276109)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">628</td><td align="left" rowspan="1" colspan="1">546</td><td align="left" rowspan="1" colspan="1">467</td><td align="left" rowspan="1" colspan="1">0.67</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.05</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>A</sub>&#x0200a;=&#x0200a;0.040</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.15</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(11.6)</td><td align="left" rowspan="1" colspan="1">(17.3)</td><td align="left" rowspan="1" colspan="1">(14.9)</td><td align="left" rowspan="1" colspan="1">(0.60&#x02013;0.76)</td><td align="left" rowspan="1" colspan="1">(0.69&#x02013;0.88)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;0.98)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">154</td><td align="left" rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">0.95</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.015</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>D</sub>&#x0200a;=&#x0200a;0.044</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.77</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(16.0)</td><td align="left" rowspan="1" colspan="1">(17.0)</td><td align="left" rowspan="1" colspan="1">(16.4)</td><td align="left" rowspan="1" colspan="1">(0.74&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;1.26)</td><td align="left" rowspan="1" colspan="1">(0.73&#x02013;1.28)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.77</td><td align="left" rowspan="1" colspan="1">3.76</td><td align="left" rowspan="1" colspan="1">0.21</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.83</td><td align="left" rowspan="1" colspan="1">
<bold><italic>P</italic></bold>
<bold><sub>R</sub>&#x0200a;=&#x0200a;0.048</bold>
</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(22.4)</td><td align="left" rowspan="1" colspan="1">(28.8)</td><td align="left" rowspan="1" colspan="1">(6.1)</td><td align="left" rowspan="1" colspan="1">(0.33&#x02013;1.78)</td><td align="left" rowspan="1" colspan="1">(0.85&#x02013;16.6)</td><td align="left" rowspan="1" colspan="1">(0.04&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="10" align="left" rowspan="1">
<italic>MMP12</italic> N122S (rs652438)</td></tr><tr><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">639</td><td align="left" rowspan="1" colspan="1">522</td><td align="left" rowspan="1" colspan="1">450</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">0.84</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.98</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.41</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;0.55</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(12.5)</td><td align="left" rowspan="1" colspan="1">(17.3)</td><td align="left" rowspan="1" colspan="1">(14.8)</td><td align="left" rowspan="1" colspan="1">(0.64&#x02013;0.81)</td><td align="left" rowspan="1" colspan="1">(0.75&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1">(0.76&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">131</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">0.77</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.90</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.37</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;0.46</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(11.7)</td><td align="left" rowspan="1" colspan="1">(16.4)</td><td align="left" rowspan="1" colspan="1">(15.2)</td><td align="left" rowspan="1" colspan="1">(0.55&#x02013;0.92)</td><td align="left" rowspan="1" colspan="1">(0.59&#x02013;1.00)</td><td align="left" rowspan="1" colspan="1">(0.70&#x02013;1.22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.52</td><td align="left" rowspan="1" colspan="1">1.31</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.84</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.24</td><td align="left" rowspan="1" colspan="1">
<italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;0.34</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(12.9)</td><td align="left" rowspan="1" colspan="1">(19.2)</td><td align="left" rowspan="1" colspan="1">(24.8)</td><td align="left" rowspan="1" colspan="1">(0.31&#x02013;1.46)</td><td align="left" rowspan="1" colspan="1">(0.24&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1">(0.59&#x02013;2.91)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt120"><label/><p>
<italic>P</italic>
<sub>A</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for additive genetic model, <italic>P</italic>
<sub>D</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for dominant genetic model, <italic>P</italic>
<sub>R</sub>&#x0200a;=&#x0200a;<italic>P</italic>-value for recessive genetic model.</p></fn><fn id="nt121"><label/><p>&#x0002a;<italic>P</italic>-value for gene-by-treatment interaction.</p></fn><fn id="nt122"><label/><p>CHF; chronic heart failure; CHL, chlorthalidone treatment group; AML, amlodipine treatment group; LIS, lisinopril treatment group.</p></fn></table-wrap-foot></table-wrap><sec id="s3b1"><title>CHD, combined CHD, and combined CVD</title><p>Participants having the <italic>MMP9</italic> R668Q minor allele homozygote (AA) genotype had lower risk of CCHD when randomized to chlorthalidone versus amlodipine (HR&#x0200a;=&#x0200a;0.64). No significant differences in CHD or CCHD were observed across AG or GG genotype-treatment groups. The <italic>P</italic>-value for the pharmacogenetic effect for CCHD in the recessive genetic model was 0.038.</p><p>Subjects with the <italic>MMP9</italic> R279Q GG genotype had lower risk of CCVD when randomized to chlorthalidone versus amlodipine or lisinopril (HR&#x0200a;=&#x0200a;0.81 and 0.78, respectively) compared with participants with at least one copy of the A allele (pharmacogenetic effect <italic>P</italic>&#x0200a;=&#x0200a;0.024 and <italic>P</italic>&#x0200a;=&#x0200a;0.026 for chlorthalidone versus amlodipine and chlorthalidone versus lisinopril, respectively in recessive models). A similar effect was observed for the CCHD outcome, with only the chlorthalidone versus lisinopril comparison reaching a <italic>P</italic>-value&#x0003c;0.05 (<italic>P</italic>&#x0200a;=&#x0200a;0.045 for the recessive model).</p><p>Participants having the <italic>MMP12</italic> N122S variant GG genotype had significantly increased rates (40.9 per 1000 p-y) of CHD if taking lisinopril versus any other genotype-treatment combination (16.3&#x02013;20.6 per 1000 p-y). This difference led to a detectable pharmacogenetic effect for both chlorthalidone versus lisinopril and lisinopril versus amlodipine comparisons (<italic>P</italic>-values for pharmacogenetic effect ranged from 0.005 to 0.041 depending on genetic model). Results for CCHD and CCVD were consistent with this observation.</p><p>For the <italic>MMP12</italic> &#x02212;82A&#x0003e;G variant, there was evidence of a pharmacogenetic effect on CCVD for the chlorthalidone versus lisinopril comparison. Homozygotes for the minor G allele had increased risk of CCVD when randomized to chlorthalidone versus lisinopril (HR&#x0200a;=&#x0200a;1.75), while the common A allele carriers had slightly reduced risk (HR&#x0200a;=&#x0200a;0.90 for AA group, HR&#x0200a;=&#x0200a;0.95 for AG group; pharmacogenetic effect <italic>P</italic>&#x0200a;=&#x0200a;0.025).</p></sec><sec id="s3b2"><title>ACM</title><p>Participants with the <italic>MMP12</italic> N122S AG and GG genotypes experienced substantially increased ACM (39&#x00025; and 28&#x00025;, respectively) on lisinopril compared to those on amlodipine, while no differences in ACM were found with the common AA genotype-treatment combinations. The <italic>P</italic>-value for the pharmacogenetic effect was 0.013 when modeled additively and 0.004 when modeled dominantly. For the chlorthalidone versus amlodipine comparison, GG participants had reduced risk on chlorthalidone (HR&#x0200a;=&#x0200a;0.81), while AG heterozygotes had increased risk (HR&#x0200a;=&#x0200a;1.32). There was no treatment effect among the common AA homozygotes (HR&#x0200a;=&#x0200a;1.01). The <italic>P</italic>-value for this pharmacogenetic effect was 0.021 when modeled additively.</p><p>Subjects having the <italic>MMP12</italic> &#x02212;82A&#x0003e;G GG genotype had significantly lower ACM on lisinopril versus amlodipine (HR&#x0200a;=&#x0200a;0.37), while those with at least one copy of the A allele had somewhat higher risk on lisinopril versus amlodipine (HR&#x0200a;=&#x0200a;1.07 and 1.12 for AA and AG groups, respectively; <italic>P</italic>&#x0200a;=&#x0200a;0.043 for the pharmacogenetic effect when modeled recessively).</p></sec><sec id="s3b3"><title>Stroke</title><p>Those subjects having <italic>MMP9</italic> R668Q common GG genotype randomized to chlorthalidone had a slightly increased risk of stroke over those with the same genotype randomized to amlodipine (HR&#x0200a;=&#x0200a;1.08), whereas participants with the AA genotype had a 3.65-fold increased risk of stroke when randomized to chlorthalidone versus amlodipine. There was no treatment effect among heterozygotes (HR&#x0200a;=&#x0200a;0.99). The <italic>P</italic>-value for the pharmacogenetic effect was marginally significant (<italic>P</italic>&#x0200a;=&#x0200a;0.048).</p></sec><sec id="s3b4"><title>HF</title><p>A pharmacogenetic effect is suggested for the <italic>MMP12</italic> &#x02212;82A&#x0003e;G polymorphism with both the chlorthalidone versus amlodipine group and the chlorthalidone versus lisinopril group comparisons. All subjects with data for the <italic>MMP12</italic> &#x02212;82A&#x0003e;G polymorphism, regardless of genotype, showed decreased risk of HF on chlorthalidone versus amlodipine. However, there was a stronger protective effect of chlorthalidone versus amlodipine among those with the common AA genotype compared to G allele carriers (HR&#x0200a;=&#x0200a;0.67 for AA group, HR&#x0200a;=&#x0200a;0.95 for AG group, HR&#x0200a;=&#x0200a;0.77 for GG group; <italic>P</italic>&#x0200a;=&#x0200a;0.015 for pharmacogenetic effect when modeled dominantly). Among those with the GG genotype, a 3.76-fold increased risk of HF was found for those subjects randomized to chlorthalidone vs. lisinopril, whereas for those with the common AA genotype the risk of HF was reduced in the chlorthalidone group versus the lisinopril group (HR&#x0200a;=&#x0200a;0.78). There was no difference in treatment effect among AG heterozygotes (HR&#x0200a;=&#x0200a;0.98). Although this pharmacogenetic effect is significant (<italic>P</italic>&#x0200a;=&#x0200a;0.040 for the additive model, <italic>P</italic>&#x0200a;=&#x0200a;0.044 for the dominant model, <italic>P</italic>&#x0200a;=&#x0200a;0.048 for the recessive model), it should be noted that there were few events (n&#x0200a;=&#x0200a;2) in the GG genotype-lisinopril group.</p></sec></sec><sec id="s3c"><title>Implications of Hardy-Weinberg disequilibrium</title><p>Because <italic>MMP12</italic> N122S and <italic>MMP9</italic> R668Q variants were not in HWE for all ethnic subgroups, we tested whether the suggestive pharmacogenetic effects would be similar if we omitted the subgroups in HW disequilibrium. Therefore, for the <italic>MMP12</italic> N122S analysis we omitted the Black-non-Hispanic participants (31&#x00025; of the overall population), and for the <italic>MMP9</italic> R668Q analysis we omitted the White-Hispanic participants (13&#x00025; of the overall population). The results of these analyses showed that for all the findings presented in <xref ref-type="table" rid="pone-0023609-t003">Tables 3</xref>, <xref ref-type="table" rid="pone-0023609-t004">4</xref>, <xref ref-type="table" rid="pone-0023609-t005">5</xref>, <xref ref-type="table" rid="pone-0023609-t006">6</xref>, <xref ref-type="table" rid="pone-0023609-t007">7</xref>, <xref ref-type="table" rid="pone-0023609-t008">8</xref> for these two variants with a <italic>P</italic>-value less than 0.05, the pharmacogenetic effect (ratio of hazard ratios) was in the same direction and, for the most part, of similar magnitude (data not shown). Due in part to reduced sample sizes, the <italic>P</italic>-values varied in most cases. In some cases the association was slightly strengthened. In cases where association was attenuated, the most disparate finding when omitting the subgroup in HW disequilibrium was found for the pharmacogenetic effect of the <italic>MMP9</italic> R668Q variant on combined CHD when comparing chlorthalidone to amlodipine: for the full group modeled recessively, the ratio of hazard ratios was 0.64 (<italic>P</italic>&#x0200a;=&#x0200a;0.04), whereas it was 0.71 (<italic>P</italic>&#x0200a;=&#x0200a;0.13) when omitting the White-Hispanic group.</p></sec></sec><sec id="s4"><title>Discussion</title><p>In this study we evaluated the pharmacogenetic effects of <italic>MMP9</italic> and <italic>MMP12</italic> variants on CHD, stroke, HF, combined CHD and CVD, and ACM. Our data provide evidence of pharmacogenetic associations between variants in the <italic>MMP9</italic> and <italic>MMP12</italic> genes and treatment for a variety of these cardiovascular outcomes: <italic>MMP9</italic> R668Q variant for both combined CHD and stroke; <italic>MMP9</italic> R279Q variant for the combined CVD outcome; and <italic>MMP12</italic> N122S variant for CHD, combined CHD, combined CVD, and ACM. Specifically, we found that patients having the <italic>MMP9</italic> R668Q AA genotype who were treated with chlorthalidone have a decreased risk of combined CHD but an increased risk of stroke compared to patients treated with amlodipine. Patients with the <italic>MMP9</italic> R279Q GG genotype treated with chlorthalidone had lower risk of combined CVD than patients treated with amlodipine or lisinopril. For those having either <italic>MMP12</italic> N122S AG or GG genotype, lisinopril treatment increased the risk of CHD, combined CHD, and combined CVD when compared to patients treated with chlorthalidone or a higher risk of CHD and ACM when compared to patients treated with amlodipine. In aggregate, these results indicate these variants may be useful in selecting appropriate antihypertensive agents to reduce risk of CVD.</p><p>Because some <italic>MMP12</italic> and <italic>MMP9</italic> variants were not in HWE for all ethnic subgroups, we investigated whether the pharmacogenetic effects would be similar if we omitted the subgroups in HW disequilibrium. These analyses showed that the pharmacogenetic effect was in the same direction and of similar magnitude with the reduced sample. We note that both the Black and Hispanic groups likely had diverse ancestry given that participants were recruited in the US, Canada, and the Caribbean; therefore, some degree of population substructure is expected. However, it should be emphasized that even if population substructure in the data leads to HW disequilibrium, which can lead to an increase in false-positive findings for <italic>main effects</italic> of genetic variants on outcomes, this should not explain any <italic>pharmacogenetic findings</italic> because participants were randomized to treatment; therefore, confounding from population substructure should be controlled because randomization in the context of a large sample size results in the same degree of population substructure in <italic>each</italic> treatment group. We conclude that, although unmeasured population substructure may be present, it is unlikely that the HW disequilibrium in some ethnic subgroups is driving our suggestive results.</p><p>MMP-9 may have a direct effect on plaque destabilization and may also serve as a biomarker predictive of mortality in patients with CVD <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>. As previously mentioned, elevated MMP-9 levels have been observed following acute coronary events <xref rid="pone.0023609-Kai1" ref-type="bibr">[5]</xref>_ENREF_16. However, Johnson et al. suggested MMP-9 is activated during healing processes as opposed to causing rupture of plaques <xref rid="pone.0023609-Johnson1" ref-type="bibr">[31]</xref>. Based on our findings, chlorthalidone and amlodipine could potentially influence MMP-9 function. Chlorthalidone, a thiazide-like diuretic, acts on the Na<sup>&#x0002b;</sup>Cl<sup>&#x02212;</sup> symporter in the kidney, leading to greatly increased sodium and chloride excretion <xref rid="pone.0023609-National1" ref-type="bibr">[32]</xref>, <xref rid="pone.0023609-DrugBank1" ref-type="bibr">[33]</xref>. Chlorthalidone's antihypertensive mechanism is not fully understood, and we are not aware of studies evaluating independent effects of chlorthalidone on MMP activity. However, Seeland et al. examined the effects of diuretic therapy in combination with an ACE inhibitor and found supplemental treatment with the diuretic furosemide did not provide additional benefit on extracellular matrix remodeling compared to ACE inhibitor alone <xref rid="pone.0023609-Seeland1" ref-type="bibr">[34]</xref>. Amlodipine is a CCB of the dihydropyridine class. It inhibits vascular smooth muscle contractions, causing increased blood flow to the heart and decreased peripheral arterial resistance and blood pressure <xref rid="pone.0023609-DrugBank2" ref-type="bibr">[35]</xref>. Zervoudaki et al. reported that amlodipine increases plasma MMP-9 levels in hypertensive patients <xref rid="pone.0023609-Zervoudaki1" ref-type="bibr">[8]</xref>, <xref rid="pone.0023609-Zervoudaki2" ref-type="bibr">[9]</xref>. However, a study involving lercanidipine (another dihydropyridine CCB) found decreased MMP-9 activity in hypertensives and suggested a mechanism involving the antioxidant effects of lercanidipine, which are shared by amlodipine <xref rid="pone.0023609-Martinez1" ref-type="bibr">[10]</xref>. A possible explanation for this discrepancy is that the amlodipine study used ELISA to measure MMP-9 level, whereas the more recent lercanidipine study used gel zymography <xref rid="pone.0023609-Martinez1" ref-type="bibr">[10]</xref>. Like other ACE inhibitors, lisinopril blocks the production of angiotensin II (a vasoconstrictor), thereby decreasing blood pressure. Like the MMPs, ACE is a zinc-dependent endopeptidase <xref rid="pone.0023609-Jin1" ref-type="bibr">[11]</xref>. Studies have shown that ACE inhibition may also inhibit MMP levels <xref rid="pone.0023609-Jin1" ref-type="bibr">[11]</xref>, <xref rid="pone.0023609-Reinhardt1" ref-type="bibr">[12]</xref>, <xref rid="pone.0023609-Yamamoto1" ref-type="bibr">[13]</xref>, <xref rid="pone.0023609-Liebetrau1" ref-type="bibr">[14]</xref>, <xref rid="pone.0023609-Takai1" ref-type="bibr">[36]</xref>, <xref rid="pone.0023609-Yamamoto2" ref-type="bibr">[37]</xref>, <xref rid="pone.0023609-Yamamoto3" ref-type="bibr">[38]</xref>. Yamamoto et al. identified two potential interaction mechanisms between lisinopril and the active site of MMP-9 <xref rid="pone.0023609-Yamamoto3" ref-type="bibr">[38]</xref>. Lisinopril was shown to be stabilized in the active site by specific hydrogen bonds, and its hydrophobic group interacted preferentially with the S1 site compared to the S1&#x02032; site <xref rid="pone.0023609-Yamamoto3" ref-type="bibr">[38]</xref>. In their subsequent work, Yamamoto et al. and Takai et al. also found that different ACE inhibitors show differential binding affinities for MMP-9 <xref rid="pone.0023609-Yamamoto1" ref-type="bibr">[13]</xref>, <xref rid="pone.0023609-Takai1" ref-type="bibr">[36]</xref>, <xref rid="pone.0023609-Yamamoto2" ref-type="bibr">[37]</xref>, <xref rid="pone.0023609-Yamamoto3" ref-type="bibr">[38]</xref>. Sakata et al. observed that ACE inhibition directly lowers MMP activity in rats, thus preventing left ventricular remodeling <xref rid="pone.0023609-Sakata1" ref-type="bibr">[39]</xref>. The <italic>MMP9</italic> R279Q polymorphism is a glutamine to arginine substitution located in the catalytic domain of MMP-9 <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>, <xref rid="pone.0023609-Hirose1" ref-type="bibr">[20]</xref> and may affect substrate binding <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>. The <italic>MMP9</italic> R668Q polymorphism is in the hemopexin-like domain and probably also functions in substrate binding, since removal of this domain disables the cleavage of triple-helix collagen <xref rid="pone.0023609-Han1" ref-type="bibr">[19]</xref>.</p><p>MMP-12 is expressed in macrophages and epithelial cells and has been implicated in the progression of atherosclerosis, wound repair, and certain cancers <xref rid="pone.0023609-Kerkela1" ref-type="bibr">[40]</xref>, <xref rid="pone.0023609-Lavigne1" ref-type="bibr">[41]</xref>. Like MMP-9, MMP-12 activity is increased following vascular injury <xref rid="pone.0023609-Matsuno1" ref-type="bibr">[42]</xref>. Plasma MMP-12 levels are increased in patients with coronary artery disease and may, therefore, be an independent risk factor for coronary artery disease <xref rid="pone.0023609-JguirimSouissi1" ref-type="bibr">[43]</xref>. Morgan et al. observed higher MMP-12 levels in thin-cap atherosclerotic plaques (those considered more prone to rupture) versus thick-cap plaques. MMP-12 levels were also elevated in already ruptured plaques, suggesting that MMP-12 has a role in plaque stability <xref rid="pone.0023609-Morgan1" ref-type="bibr">[44]</xref>. Based on our findings, chlorthalidone, lisinopril, and amlodipine could potentially affect MMP-12 activity. To our knowledge, studies have not evaluated the effects of diuretics, ACE inhibitors, or CCBs on MMP-12. However, based on the finding that lercanidipine may inhibit macrophage function and the fact that macrophages secrete MMP-12, we hypothesize that CCBs may decrease MMP-12 levels <xref rid="pone.0023609-Kerkela1" ref-type="bibr">[40]</xref>, <xref rid="pone.0023609-Canavesi1" ref-type="bibr">[45]</xref>. The MMP12 &#x02212;82A&#x0003e;G polymorphism lies in the <italic>MMP12</italic> gene promoter <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>. The <italic>MMP12</italic> &#x02212;82A&#x0003e;G polymorphism affects AP-1 binding affinity, with the A allele showing a higher affinity for the protein and, therefore, higher <italic>MMP12</italic> promoter activity <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>, <xref rid="pone.0023609-Joos1" ref-type="bibr">[18]</xref>. <italic>MMP12</italic> N122S is an asparagine to serine substitution located in the coding region of the <italic>MMP12</italic> hemopexin domain, which is responsible for gene activity <xref rid="pone.0023609-Su1" ref-type="bibr">[17]</xref>, <xref rid="pone.0023609-Joos1" ref-type="bibr">[18]</xref>. To our knowledge, no pharmacogenetic studies have been done on this combination of polymorphisms, drugs, and outcomes.</p><p>Our data suggest associations between the <italic>MMP9</italic> R279Q polymorphism and stroke and between the <italic>MMP12</italic> N122S polymorphism and combined CHD. The <italic>MMP9</italic> R279Q polymorphism has been associated with increased intima-media thickness <xref rid="pone.0023609-Armstrong1" ref-type="bibr">[46]</xref>, an independent predictor of MI and stroke risk <xref rid="pone.0023609-Bots1" ref-type="bibr">[47]</xref>. Blankenberg et al. found that <italic>MMP9</italic> R279Q had no effect on plasma MMP-9 concentration but was associated with future cardiovascular events in patients with stable angina <xref rid="pone.0023609-Blankenberg1" ref-type="bibr">[16]</xref>. This polymorphism also influences aortic stiffness, which is a determinant of cardiovascular risk <xref rid="pone.0023609-Yasmin1" ref-type="bibr">[48]</xref>. We also found a pharmacogenetic effect of the <italic>MMP9</italic> R668Q polymorphism to increased stroke risk, although this association may be due to the small number of events (17 in the chlorthalidone group, 3 in the amlodipine group). The <italic>MMP12</italic> &#x02212;82A&#x0003e;G polymorphism has been associated with coronary atherosclerosis <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>, <xref rid="pone.0023609-Ye1" ref-type="bibr">[49]</xref>, <xref rid="pone.0023609-Ye2" ref-type="bibr">[50]</xref>. A study by Jormsjo et al. suggests this polymorphism is associated with narrowing of coronary arteries in diabetic patients with CHD <xref rid="pone.0023609-Jormsjo1" ref-type="bibr">[15]</xref>, <xref rid="pone.0023609-Ye2" ref-type="bibr">[50]</xref>.</p><p>GenHAT is an ancillary study of ALLHAT. The ALLHAT study population included only those over age 55 with hypertension. As a result, our findings may not be generalizable to younger age groups. An additional limitation is that we looked at only four MMP polymorphisms. There may be unknown polymorphisms in these genes or combinations of polymorphisms affecting the findings. Since we performed multiple tests of pharmacogenetic effects, these findings would not meet the threshold of statistical significance if corrected for multiple testing (Bonferroni correction: 0.05/72 tests would equate to a <italic>P</italic>-value of 0.0007). However, given the possibility of linkage disequilibrium between variants and non-mutually exclusive outcomes, this threshold is overly conservative. Nevertheless, the likelihood that these findings are false positives is not negligible, and independent replication is necessary. At this time, there are no other large clinical trials that are outcome-based like ALLHAT in which results can be replicated. Our findings and the findings of other studies suggest that future studies might fruitfully investigate the functional interactions of MMP-9 and MMP-12 with diuretics, ACE inhibitors, and CCBs. This study has several strengths. The ALLHAT trial was a large, double-blind randomized trial. Additionally, the study population showed exceptional ethnic and gender diversity (about 50&#x00025; non-White, about 50&#x00025; female) <xref rid="pone.0023609-Arnett1" ref-type="bibr">[26]</xref>. Our results were not sensitive to departures from HWE in various ethnic groups.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>BD has twice served as a consultant on the Takeda Pharmaceuticals Data Safety Monitoring Board and has received one honoraria for work done for Forest Laboratories. VB is employed by Roche Molecular Systems, Inc., a company with no current business interests in cardiovascular disease. These potential competing interests in no way compromise the authors' adherence to PLoS ONE data and material sharing policies. All other authors disclosed no potential conflicts of interest.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This study was supported by grants HL63082 (Genetics of Hypertension Associated Treatments, (GenHAT)) from the National Heart, Lung, and Blood Institute (<ext-link ext-link-type="uri" xlink:href="http://www.nhlbi.nih.gov">http://www.nhlbi.nih.gov</ext-link>) and N01-HC-35130 (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, (ALLHAT)) from the National Institutes of Health (<ext-link ext-link-type="uri" xlink:href="http://www.nih.gov">http://www.nih.gov</ext-link>). The National Heart, Lung, and Blood Institute had a contributing role in the analysis and interpretation of the ALLHAT data and in the review and approval of this GenHAT article.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0023609-Galis1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galis</surname><given-names>ZS</given-names></name><name><surname>Khatri</surname><given-names>JJ</given-names></name></person-group>
<year>2002</year>
<article-title>Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.</article-title>
<source>Circ Res</source>
<volume>90</volume>
<fpage>251</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="pmid">11861412</pub-id></element-citation></ref><ref id="pone.0023609-Hlatky1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hlatky</surname><given-names>MA</given-names></name><name><surname>Ashley</surname><given-names>E</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Boothroyd</surname><given-names>DB</given-names></name><name><surname>Ridker</surname><given-names>P</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.</article-title>
<source>Am Heart J</source>
<volume>154</volume>
<fpage>1043</fpage>
<lpage>1051</lpage>
<pub-id pub-id-type="pmid">18035073</pub-id></element-citation></ref><ref id="pone.0023609-Hutchinson1"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>KR</given-names></name><name><surname>Stewart</surname><given-names>JA</given-names><suffix>Jr</suffix></name><name><surname>Lucchesi</surname><given-names>PA</given-names></name></person-group>
<year>2009</year>
<article-title>Extracellular matrix remodeling during the progression of volume overload-induced heart failure.</article-title>
<source>J Mol Cell Cardiol</source>
</element-citation></ref><ref id="pone.0023609-Zhou1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Feely</surname><given-names>J</given-names></name><name><surname>Spiers</surname><given-names>JP</given-names></name><name><surname>Mahmud</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension.</article-title>
<source>J Hum Hypertens</source>
<volume>21</volume>
<fpage>861</fpage>
<lpage>867</lpage>
<pub-id pub-id-type="pmid">17581602</pub-id></element-citation></ref><ref id="pone.0023609-Kai1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kai</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>H</given-names></name><name><surname>Yasukawa</surname><given-names>H</given-names></name><name><surname>Kai</surname><given-names>M</given-names></name><name><surname>Seki</surname><given-names>Y</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.</article-title>
<source>J Am Coll Cardiol</source>
<volume>32</volume>
<fpage>368</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">9708462</pub-id></element-citation></ref><ref id="pone.0023609-Liang1"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Kitajima</surname><given-names>S</given-names></name><name><surname>Koike</surname><given-names>T</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits.</article-title>
<source>Circulation</source>
<volume>113</volume>
<fpage>1993</fpage>
<lpage>2001</lpage>
<pub-id pub-id-type="pmid">16636188</pub-id></element-citation></ref><ref id="pone.0023609-Yamada1"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Tanimoto</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Shimajiri</surname><given-names>S</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits.</article-title>
<source>Am J Pathol</source>
<volume>172</volume>
<fpage>1419</fpage>
<lpage>1429</lpage>
<pub-id pub-id-type="pmid">18403602</pub-id></element-citation></ref><ref id="pone.0023609-Zervoudaki1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zervoudaki</surname><given-names>A</given-names></name><name><surname>Economou</surname><given-names>E</given-names></name><name><surname>Pitsavos</surname><given-names>C</given-names></name><name><surname>Vasiliadou</surname><given-names>K</given-names></name><name><surname>Aggeli</surname><given-names>C</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>The effect of Ca2&#x0002b; channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.</article-title>
<source>Am J Hypertens</source>
<volume>17</volume>
<fpage>273</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="pmid">15001203</pub-id></element-citation></ref><ref id="pone.0023609-Zervoudaki2"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zervoudaki</surname><given-names>A</given-names></name><name><surname>Economou</surname><given-names>E</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name><name><surname>Pitsavos</surname><given-names>C</given-names></name><name><surname>Tsioufis</surname><given-names>K</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment.</article-title>
<source>J Hum Hypertens</source>
<volume>17</volume>
<fpage>119</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">12574790</pub-id></element-citation></ref><ref id="pone.0023609-Martinez1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martinez</surname><given-names>ML</given-names></name><name><surname>Lopes</surname><given-names>LF</given-names></name><name><surname>Coelho</surname><given-names>EB</given-names></name><name><surname>Nobre</surname><given-names>F</given-names></name><name><surname>Rocha</surname><given-names>JB</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.</article-title>
<source>J Cardiovasc Pharmacol</source>
<volume>47</volume>
<fpage>117</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">16424795</pub-id></element-citation></ref><ref id="pone.0023609-Jin1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>HC</given-names></name><name><surname>Lindsey</surname><given-names>ML</given-names></name></person-group>
<year>2007</year>
<article-title>ACE inhibitors to block MMP-9 activity: new functions for old inhibitors.</article-title>
<source>J Mol Cell Cardiol</source>
<volume>43</volume>
<fpage>664</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="pmid">17949743</pub-id></element-citation></ref><ref id="pone.0023609-Reinhardt1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reinhardt</surname><given-names>D</given-names></name><name><surname>Sigusch</surname><given-names>HH</given-names></name><name><surname>Hensse</surname><given-names>J</given-names></name><name><surname>Tyagi</surname><given-names>SC</given-names></name><name><surname>Korfer</surname><given-names>R</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.</article-title>
<source>Heart</source>
<volume>88</volume>
<fpage>525</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">12381651</pub-id></element-citation></ref><ref id="pone.0023609-Yamamoto1"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>D</given-names></name><name><surname>Takai</surname><given-names>S</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group>
<year>2008</year>
<article-title>Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.</article-title>
<source>Eur J Pharmacol</source>
<volume>588</volume>
<fpage>277</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="pmid">18501888</pub-id></element-citation></ref><ref id="pone.0023609-Liebetrau1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liebetrau</surname><given-names>M</given-names></name><name><surname>Burggraf</surname><given-names>D</given-names></name><name><surname>Wunderlich</surname><given-names>N</given-names></name><name><surname>Jager</surname><given-names>G</given-names></name><name><surname>Linz</surname><given-names>W</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.</article-title>
<source>Neurosci Lett</source>
<volume>376</volume>
<fpage>205</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">15721222</pub-id></element-citation></ref><ref id="pone.0023609-Jormsjo1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jormsjo</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Moritz</surname><given-names>J</given-names></name><name><surname>Walter</surname><given-names>DH</given-names></name><name><surname>Dimmeler</surname><given-names>S</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.</article-title>
<source>Circ Res</source>
<volume>86</volume>
<fpage>998</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="pmid">10807873</pub-id></element-citation></ref><ref id="pone.0023609-Blankenberg1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blankenberg</surname><given-names>S</given-names></name><name><surname>Rupprecht</surname><given-names>HJ</given-names></name><name><surname>Poirier</surname><given-names>O</given-names></name><name><surname>Bickel</surname><given-names>C</given-names></name><name><surname>Smieja</surname><given-names>M</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.</article-title>
<source>Circulation</source>
<volume>107</volume>
<fpage>1579</fpage>
<lpage>1585</lpage>
<pub-id pub-id-type="pmid">12668489</pub-id></element-citation></ref><ref id="pone.0023609-Su1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Asomaning</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Wain</surname><given-names>JC</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.</article-title>
<source>Carcinogenesis</source>
<volume>27</volume>
<fpage>1024</fpage>
<lpage>1029</lpage>
<pub-id pub-id-type="pmid">16311244</pub-id></element-citation></ref><ref id="pone.0023609-Joos1"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joos</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>JQ</given-names></name><name><surname>Shepherdson</surname><given-names>MB</given-names></name><name><surname>Connett</surname><given-names>JE</given-names></name><name><surname>Anthonisen</surname><given-names>NR</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.</article-title>
<source>Hum Mol Genet</source>
<volume>11</volume>
<fpage>569</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="pmid">11875051</pub-id></element-citation></ref><ref id="pone.0023609-Han1"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>HN</given-names></name><name><surname>Yoon</surname><given-names>JK</given-names></name><name><surname>Yi</surname><given-names>SY</given-names></name><name><surname>Moon</surname><given-names>HS</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis.</article-title>
<source>Fertil Steril</source>
<volume>91</volume>
<fpage>2324</fpage>
<lpage>2330</lpage>
<pub-id pub-id-type="pmid">18554596</pub-id></element-citation></ref><ref id="pone.0023609-Hirose1"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirose</surname><given-names>Y</given-names></name><name><surname>Chiba</surname><given-names>K</given-names></name><name><surname>Karasugi</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Kawaguchi</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation.</article-title>
<source>Am J Hum Genet</source>
<volume>82</volume>
<fpage>1122</fpage>
<lpage>1129</lpage>
<pub-id pub-id-type="pmid">18455130</pub-id></element-citation></ref><ref id="pone.0023609-Natividad1"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Natividad</surname><given-names>A</given-names></name><name><surname>Cooke</surname><given-names>G</given-names></name><name><surname>Holland</surname><given-names>MJ</given-names></name><name><surname>Burton</surname><given-names>MJ</given-names></name><name><surname>Joof</surname><given-names>HM</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.</article-title>
<source>BMC Med Genet</source>
<volume>7</volume>
<fpage>40</fpage>
<pub-id pub-id-type="pmid">16643654</pub-id></element-citation></ref><ref id="pone.0023609-Shin1"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>A</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group>
<year>2005</year>
<article-title>Genetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai Breast Cancer Study.</article-title>
<source>Breast Cancer Res</source>
<volume>7</volume>
<fpage>R506</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="pmid">15987457</pub-id></element-citation></ref><ref id="pone.0023609-Kure1"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kure</surname><given-names>M</given-names></name><name><surname>Pezzolesi</surname><given-names>MG</given-names></name><name><surname>Poznik</surname><given-names>GD</given-names></name><name><surname>Katavetin</surname><given-names>P</given-names></name><name><surname>Skupien</surname><given-names>J</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.</article-title>
<source>Mol Genet Metab</source>
</element-citation></ref><ref id="pone.0023609-ALLHAT1"><label>24</label><element-citation publication-type="journal">
<collab>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group</collab>
<year>2002</year>
<article-title>Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).</article-title>
<source>Jama</source>
<volume>288</volume>
<fpage>2981</fpage>
<lpage>2997</lpage>
<pub-id pub-id-type="pmid">12479763</pub-id></element-citation></ref><ref id="pone.0023609-Antihypertensive1"><label>25</label><element-citation publication-type="journal">
<collab>Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group</collab>
<year>2003</year>
<article-title>Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).</article-title>
<source>Hypertension</source>
<volume>42</volume>
<fpage>239</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">12925554</pub-id></element-citation></ref><ref id="pone.0023609-Arnett1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>BR</given-names></name><name><surname>Eckfeldt</surname><given-names>J</given-names></name><name><surname>Ford</surname><given-names>CE</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study.</article-title>
<source>Pharmacogenomics J</source>
<volume>2</volume>
<fpage>309</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">12439737</pub-id></element-citation></ref><ref id="pone.0023609-ALLHAT2"><label>27</label><element-citation publication-type="journal">
<collab>ALLHAT Collaborative Research Group</collab>
<year>2000</year>
<article-title>Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).</article-title>
<source>Jama</source>
<volume>283</volume>
<fpage>1967</fpage>
<lpage>1975</lpage>
<pub-id pub-id-type="pmid">10789664</pub-id></element-citation></ref><ref id="pone.0023609-Davis1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>BR</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Gordon</surname><given-names>DJ</given-names></name><name><surname>Furberg</surname><given-names>CD</given-names></name><name><surname>Wright</surname><given-names>JT</given-names><suffix>Jr</suffix></name><etal/></person-group>
<year>1996</year>
<article-title>Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.</article-title>
<source>Am J Hypertens</source>
<volume>9</volume>
<fpage>342</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">8722437</pub-id></element-citation></ref><ref id="pone.0023609-Lynch1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lynch</surname><given-names>AI</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>BR</given-names></name><name><surname>Ford</surname><given-names>CE</given-names></name><name><surname>Eckfeldt</surname><given-names>JH</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.</article-title>
<source>Jama</source>
<volume>299</volume>
<fpage>296</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="pmid">18212314</pub-id></element-citation></ref><ref id="pone.0023609-Burns1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burns</surname><given-names>JC</given-names></name><name><surname>Shimizu</surname><given-names>C</given-names></name><name><surname>Shike</surname><given-names>H</given-names></name><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Sundel</surname><given-names>RP</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.</article-title>
<source>Genes Immun</source>
<volume>6</volume>
<fpage>438</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="pmid">15889128</pub-id></element-citation></ref><ref id="pone.0023609-Johnson1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>George</surname><given-names>SJ</given-names></name><name><surname>Newby</surname><given-names>AC</given-names></name><name><surname>Jackson</surname><given-names>CL</given-names></name></person-group>
<year>2005</year>
<article-title>Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>102</volume>
<fpage>15575</fpage>
<lpage>15580</lpage>
<pub-id pub-id-type="pmid">16221765</pub-id></element-citation></ref><ref id="pone.0023609-National1"><label>32</label><element-citation publication-type="other">
<collab>National Library of Medicine, US National Institutes of Health</collab>
<article-title>Chlorthalidone Tablet.</article-title>
<comment>Daily Med: Current Medication Information web site. Available: <ext-link ext-link-type="uri" xlink:href="http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acee7938-90a7-4d6a-a205-d4670a031d43">http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acee7938-90a7-4d6a-a205-d4670a031d43</ext-link>. Accessed 2008 July 23</comment>
</element-citation></ref><ref id="pone.0023609-DrugBank1"><label>33</label><element-citation publication-type="other">
<collab>DrugBank</collab>
<article-title>Chlorthalidone.</article-title>
<comment>DrugBank web site. Available: <ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca/drugs/DB00310">http://www.drugbank.ca/drugs/DB00310</ext-link>. Accessed 2009 July 31</comment>
</element-citation></ref><ref id="pone.0023609-Seeland1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seeland</surname><given-names>U</given-names></name><name><surname>Kouchi</surname><given-names>I</given-names></name><name><surname>Zolk</surname><given-names>O</given-names></name><name><surname>Itter</surname><given-names>G</given-names></name><name><surname>Linz</surname><given-names>W</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.</article-title>
<source>J Mol Cell Cardiol</source>
<volume>34</volume>
<fpage>151</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">11851355</pub-id></element-citation></ref><ref id="pone.0023609-DrugBank2"><label>35</label><element-citation publication-type="other">
<collab>DrugBank</collab>
<article-title>Amlodipine.</article-title>
<comment>DrugBank web site. Available: <ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca/drugs/DB00381">http://www.drugbank.ca/drugs/DB00381</ext-link>. Accessed 2009 July 31</comment>
</element-citation></ref><ref id="pone.0023609-Takai1"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takai</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Inagaki</surname><given-names>S</given-names></name><name><surname>Yoshikawa</surname><given-names>K</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters.</article-title>
<source>Eur J Pharmacol</source>
<volume>568</volume>
<fpage>231</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="pmid">17512521</pub-id></element-citation></ref><ref id="pone.0023609-Yamamoto2"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>D</given-names></name><name><surname>Takai</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Inagaki</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9.</article-title>
<source>J Mol Cell Cardiol</source>
<volume>43</volume>
<fpage>670</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="pmid">17884087</pub-id></element-citation></ref><ref id="pone.0023609-Yamamoto3"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>D</given-names></name><name><surname>Takai</surname><given-names>S</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group>
<year>2007</year>
<article-title>Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site.</article-title>
<source>Biochem Biophys Res Commun</source>
<volume>354</volume>
<fpage>981</fpage>
<lpage>984</lpage>
<pub-id pub-id-type="pmid">17275782</pub-id></element-citation></ref><ref id="pone.0023609-Sakata1"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakata</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Mano</surname><given-names>T</given-names></name><name><surname>Nishikawa</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>J</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor.</article-title>
<source>Circulation</source>
<volume>109</volume>
<fpage>2143</fpage>
<lpage>2149</lpage>
<pub-id pub-id-type="pmid">15051632</pub-id></element-citation></ref><ref id="pone.0023609-Kerkela1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kerkela</surname><given-names>E</given-names></name><name><surname>Bohling</surname><given-names>T</given-names></name><name><surname>Herva</surname><given-names>R</given-names></name><name><surname>Uria</surname><given-names>JA</given-names></name><name><surname>Saarialho-Kere</surname><given-names>U</given-names></name></person-group>
<year>2001</year>
<article-title>Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation.</article-title>
<source>Bone</source>
<volume>29</volume>
<fpage>487</fpage>
<lpage>493</lpage>
<pub-id pub-id-type="pmid">11704502</pub-id></element-citation></ref><ref id="pone.0023609-Lavigne1"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lavigne</surname><given-names>MC</given-names></name><name><surname>Thakker</surname><given-names>P</given-names></name><name><surname>Gunn</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Miyashiro</surname><given-names>JS</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Human bronchial epithelial cells express and secrete MMP-12.</article-title>
<source>Biochem Biophys Res Commun</source>
<volume>324</volume>
<fpage>534</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">15474460</pub-id></element-citation></ref><ref id="pone.0023609-Matsuno1"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuno</surname><given-names>H</given-names></name><name><surname>Ishisaki</surname><given-names>A</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Kozawa</surname><given-names>O</given-names></name></person-group>
<year>2004</year>
<article-title>Effect of a synthetic matrix metalloproteinase inhibitor (ONO-4817) on neointima formation in hypercholesterolemic hamsters.</article-title>
<source>J Cardiovasc Pharmacol</source>
<volume>44</volume>
<fpage>57</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">15175558</pub-id></element-citation></ref><ref id="pone.0023609-JguirimSouissi1"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jguirim-Souissi</surname><given-names>I</given-names></name><name><surname>Jelassi</surname><given-names>A</given-names></name><name><surname>Addad</surname><given-names>F</given-names></name><name><surname>Hassine</surname><given-names>M</given-names></name><name><surname>Najah</surname><given-names>M</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease.</article-title>
<source>Am J Cardiol</source>
<volume>100</volume>
<fpage>23</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">17599435</pub-id></element-citation></ref><ref id="pone.0023609-Morgan1"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AR</given-names></name><name><surname>Rerkasem</surname><given-names>K</given-names></name><name><surname>Gallagher</surname><given-names>PJ</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Morris</surname><given-names>GE</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics.</article-title>
<source>Stroke</source>
<volume>35</volume>
<fpage>1310</fpage>
<lpage>1315</lpage>
<pub-id pub-id-type="pmid">15073384</pub-id></element-citation></ref><ref id="pone.0023609-Canavesi1"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canavesi</surname><given-names>M</given-names></name><name><surname>Baldini</surname><given-names>N</given-names></name><name><surname>Leonardi</surname><given-names>A</given-names></name><name><surname>Sironi</surname><given-names>G</given-names></name><name><surname>Bellosta</surname><given-names>S</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>In vitro inhibitory effect of lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophages.</article-title>
<source>J Cardiovasc Pharmacol</source>
<volume>44</volume>
<fpage>416</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="pmid">15454849</pub-id></element-citation></ref><ref id="pone.0023609-Armstrong1"><label>46</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>C</given-names></name><name><surname>Abilleira</surname><given-names>S</given-names></name><name><surname>Sitzer</surname><given-names>M</given-names></name><name><surname>Markus</surname><given-names>HS</given-names></name><name><surname>Bevan</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness.</article-title>
<source>Stroke</source>
<volume>38</volume>
<fpage>2895</fpage>
<lpage>2899</lpage>
<pub-id pub-id-type="pmid">17901377</pub-id></element-citation></ref><ref id="pone.0023609-Bots1"><label>47</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bots</surname><given-names>ML</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name></person-group>
<year>1997</year>
<article-title>Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study.</article-title>
<source>Stroke</source>
<volume>28</volume>
<fpage>2442</fpage>
<lpage>2447</lpage>
<pub-id pub-id-type="pmid">9412629</pub-id></element-citation></ref><ref id="pone.0023609-Yasmin1"><label>48</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yasmin</surname></name><name><surname>McEniery</surname><given-names>CM</given-names></name><name><surname>O'Shaughnessy</surname><given-names>KM</given-names></name><name><surname>Harnett</surname><given-names>P</given-names></name><name><surname>Arshad</surname><given-names>A</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals.</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<volume>26</volume>
<fpage>1799</fpage>
<lpage>1805</lpage>
<pub-id pub-id-type="pmid">16709939</pub-id></element-citation></ref><ref id="pone.0023609-Ye1"><label>49</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>S</given-names></name></person-group>
<year>2006</year>
<article-title>Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.</article-title>
<source>Cardiovasc Res</source>
<volume>69</volume>
<fpage>636</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="pmid">16122719</pub-id></element-citation></ref><ref id="pone.0023609-Ye2"><label>50</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>S</given-names></name></person-group>
<year>2000</year>
<article-title>Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.</article-title>
<source>Matrix Biol</source>
<volume>19</volume>
<fpage>623</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="pmid">11102751</pub-id></element-citation></ref></ref-list></back></article>